Lifetime Brands (LCUT) 10-Q 7 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Oct. 31, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Trading Symbol	LCUT
Entity Registrant Name	LIFETIME BRANDS, INC
Entity Central Index Key	0000874396
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		21,256,793

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash and cash equivalents	$ 4,761	$ 7,647
Accounts receivable, less allowances of $9,345,000 at September 30, 2019 and $7,855,000 at December 31, 2018	161,935	125,292
Inventory	229,947	173,601
Prepaid expenses and other current assets	9,842	10,822
Income taxes receivable	0	1,442
TOTAL CURRENT ASSETS	406,485	318,804
PROPERTY AND EQUIPMENT, net	28,229	25,762
OPERATING LEASE RIGHT-OF-USE ASSETS	108,323
INVESTMENTS	20,347	22,582
INTANGIBLE ASSETS, net	316,343	338,847
DEFERRED INCOME TAXES	80	733
OTHER ASSETS	3,925	1,844
TOTAL ASSETS	883,732	708,572
CURRENT LIABILITIES
Current maturity of term loan	4,264	1,253
Accounts payable	67,784	38,167
Accrued expenses	58,252	45,456
Income taxes payable	4,420	0
Current portion of operating lease liabilities	10,741
TOTAL CURRENT LIABILITIES	145,461	84,876
DEFERRED RENT & OTHER LONG-TERM LIABILITIES	10,987	23,339
DEFERRED INCOME TAXES	14,947	15,141
OPERATING LEASE LIABILITIES	113,506
INCOME TAXES PAYABLE, LONG-TERM	949	949
REVOLVING CREDIT FACILITY	91,212	42,080
TERM LOAN	258,745	262,694
STOCKHOLDERS’ EQUITY
Preferred stock, $1.00 par value, shares authorized: 100 shares of Series A and 2,000,000 shares of Series B; none issued and outstanding	0	0
Common stock, $.01 par value, shares authorized: 50,000,000 at September 30, 2019 and December 31, 2018; shares issued and outstanding: 21,256,793 at September 30, 2019 and 20,764,143 at December 31, 2018	213	208
Paid-in capital	261,959	258,637
Retained earnings	22,634	55,264
Accumulated other comprehensive loss	(36,881)	(34,616)
TOTAL STOCKHOLDERS’ EQUITY	247,925	279,493
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 883,732	$ 708,572

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Accounts receivable, allowances	$ 9,345	$ 7,855
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	21,256,793	20,764,143
Common stock, shares outstanding (in shares)	21,256,793	20,764,143
Preferred stock Series A
Preferred stock, par value (usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	100	100
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Preferred stock Series B
Preferred stock, par value (usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	2,000,000	2,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Net sales	$ 215,502	$ 209,448	$ 507,964	$ 476,268
Cost of sales	142,561	135,663	336,683	305,318
Gross margin	72,941	73,785	171,281	170,950
Distribution expenses	18,537	16,612	49,938	49,376
Selling, general and administrative expenses	37,389	42,113	118,379	122,330
Restructuring expenses	338	552	1,119	1,353
Impairment of goodwill	9,748	2,205	9,748	2,205
Income (loss) from operations	6,929	12,303	(7,903)	(4,314)
Interest expense	(5,172)	(5,634)	(14,788)	(12,413)
Loss on early retirement of debt	0	0	0	(66)
Income (loss) before income taxes and equity in (losses) earnings	1,757	6,669	(22,691)	(16,793)
Income tax (provision) benefit	(15,066)	(906)	(6,813)	4,669
Equity in (losses) earnings, net of taxes	(210)	185	(395)	417
NET (LOSS) INCOME	$ (13,519)	$ 5,948	$ (29,899)	$ (11,707)
BASIC (LOSS) INCOME PER COMMON SHARE (usd per share)	$ (0.66)	$ 0.29	$ (1.46)	$ (0.61)
DILUTED (LOSS) INCOME PER COMMON SHARE (usd per share)	$ (0.66)	$ 0.29	$ (1.46)	$ (0.61)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (13,519)	$ 5,948	$ (29,899)	$ (11,707)
Other comprehensive loss, net of taxes:
Translation adjustment	(2,385)	124	(4,032)	(1,985)
Net change in cash flow hedges	151	(381)	1,729	(658)
Effect of retirement benefit obligations	13	19	38	54
Other comprehensive loss, net of taxes	(2,221)	(238)	(2,265)	(2,589)
Comprehensive (loss) income	$ (15,740)	$ 5,710	$ (32,164)	$ (14,296)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common stock	Paid-in capital	Retained earnings	Accumulated other comprehensive loss
Beginning Balance (in shares) at Dec. 31, 2017			14,903,000
Balance at beginning of year at Dec. 31, 2017		$ 210,279	$ 149	$ 178,909	$ 60,546	$ (29,325)
Comprehensive loss:
Net (loss) income		(11,598)			(11,598)
Translation adjustment		3,380				3,380
Derivative fair value adjustment		(14)				(14)
Effect of retirement benefit obligations		18				18
Comprehensive (loss) income		$ (8,214)
Issuance of 5,593,116 shares of common stock for acquisition of Filament, net of equity issuance costs (in shares)		5,593,116	5,593,000
Issuance of 5,593,116 shares of common stock for acquisition of Filament, net of equity issuance costs		$ 75,976	$ 56	75,920
Restricted shares issued to directors (in shares)			3,000
Net issuance of restricted shares to employees (in shares)			126,000
Net issuance of restricted shares to employees			$ 1	(1)
Stock compensation expense		838		838
Shares effectively repurchased for required employee withholding taxes (in shares)			(19,000)
Shares effectively repurchased for required employee withholding taxes		(258)		(258)
Dividends	[1]	(880)			(880)
Ending Balance (in shares) at Mar. 31, 2018			20,606,000
Balance at end of year at Mar. 31, 2018		277,741	$ 206	255,408	48,068	(25,941)
Beginning Balance (in shares) at Dec. 31, 2017			14,903,000
Balance at beginning of year at Dec. 31, 2017		210,279	$ 149	178,909	60,546	(29,325)
Comprehensive loss:
Net (loss) income		(11,707)
Translation adjustment		(1,985)
Derivative fair value adjustment		(658)
Effect of retirement benefit obligations		54
Comprehensive (loss) income		(14,296)
Ending Balance (in shares) at Sep. 30, 2018			20,762,000
Balance at end of year at Sep. 30, 2018		272,010	$ 208	257,547	46,169	(31,914)
Beginning Balance (in shares) at Mar. 31, 2018			20,606,000
Balance at beginning of year at Mar. 31, 2018		277,741	$ 206	255,408	48,068	(25,941)
Comprehensive loss:
Net (loss) income		(6,057)			(6,057)
Translation adjustment		(5,489)				(5,489)
Derivative fair value adjustment		(263)				(263)
Effect of retirement benefit obligations		17				17
Comprehensive (loss) income		(11,792)
Filament net equity issuance costs adjustment		(6)		(6)
Restricted shares issued to directors (in shares)			54,000
Net issuance of restricted shares to employees (in shares)			93,000
Net issuance of restricted shares to employees			$ 1	(1)
Stock compensation expense		921		921
Shares effectively repurchased for required employee withholding taxes (in shares)			(12,000)
Shares effectively repurchased for required employee withholding taxes		(140)		(140)
Dividends	[1]	(885)			(885)
Ending Balance (in shares) at Jun. 30, 2018			20,741,000
Balance at end of year at Jun. 30, 2018		265,839	$ 207	256,182	41,126	(31,676)
Comprehensive loss:
Net (loss) income		5,948			5,948
Translation adjustment		124				124
Derivative fair value adjustment		(381)				(381)
Effect of retirement benefit obligations		19				19
Comprehensive (loss) income		5,710
Net issuance of restricted shares to employees (in shares)			25,000
Net issuance of restricted shares to employees		1	$ 1
Stock compensation expense		1,268		1,268
Net exercise of stock options		142		142
Shares effectively repurchased for required employee withholding taxes (in shares)			(4,000)
Shares effectively repurchased for required employee withholding taxes		(45)		(45)
Dividends	[1]	(905)			(905)
Ending Balance (in shares) at Sep. 30, 2018			20,762,000
Balance at end of year at Sep. 30, 2018		272,010	$ 208	257,547	46,169	(31,914)
Beginning Balance (in shares) at Dec. 31, 2018			20,764,000
Balance at beginning of year at Dec. 31, 2018		279,493	$ 208	258,637	55,264	(34,616)
Comprehensive loss:
Net (loss) income		(4,867)			(4,867)
Translation adjustment		1,306				1,306
Derivative fair value adjustment		596				596
Effect of retirement benefit obligations		13				13
Comprehensive (loss) income		(2,952)
Net issuance of restricted shares to employees (in shares)			169,000
Net issuance of restricted shares to employees			$ 1	(1)
Stock compensation expense		900		900
Net exercise of stock options (in shares)			19,000
Shares effectively repurchased for required employee withholding taxes (in shares)			(25,000)
Shares effectively repurchased for required employee withholding taxes		(232)		(232)
Dividends	[2]	(898)			(898)
Ending Balance (in shares) at Mar. 31, 2019			20,927,000
Balance at end of year at Mar. 31, 2019		276,311	$ 209	259,304	49,499	(32,701)
Beginning Balance (in shares) at Dec. 31, 2018			20,764,000
Balance at beginning of year at Dec. 31, 2018		279,493	$ 208	258,637	55,264	(34,616)
Comprehensive loss:
Net (loss) income		(29,899)
Translation adjustment		(4,032)
Derivative fair value adjustment		1,729
Effect of retirement benefit obligations		38
Comprehensive (loss) income		$ (32,164)
Net exercise of stock options (in shares)		75,000
Ending Balance (in shares) at Sep. 30, 2019			21,256,000
Balance at end of year at Sep. 30, 2019		$ 247,925	$ 213	261,959	22,634	(36,881)
Beginning Balance (in shares) at Mar. 31, 2019			20,927,000
Balance at beginning of year at Mar. 31, 2019		276,311	$ 209	259,304	49,499	(32,701)
Comprehensive loss:
Net (loss) income		(11,513)			(11,513)
Translation adjustment		(2,953)				(2,953)
Derivative fair value adjustment		982				982
Effect of retirement benefit obligations		12				12
Comprehensive (loss) income		(13,472)
Restricted shares issued to directors (in shares)			61,000
Restricted shares issued to directors			$ 1	(1)
Net issuance of restricted shares to employees (in shares)			250,000
Net issuance of restricted shares to employees			$ 3	(3)
Stock compensation expense		1,186		1,186
Net exercise of stock options (in shares)			34,000
Net exercise of stock options		133		133
Shares effectively repurchased for required employee withholding taxes (in shares)			(17,000)
Shares effectively repurchased for required employee withholding taxes		(158)		(158)
Dividends	[2]	(896)			(896)
Ending Balance (in shares) at Jun. 30, 2019			21,255,000
Balance at end of year at Jun. 30, 2019		263,104	$ 213	260,461	37,090	(34,660)
Comprehensive loss:
Net (loss) income		(13,519)			(13,519)
Translation adjustment		(2,385)				(2,385)
Derivative fair value adjustment		151				151
Effect of retirement benefit obligations		13				13
Comprehensive (loss) income		(15,740)
Restricted shares issued to directors (in shares)			1,000
Restricted shares issued to directors		0
Net issuance of restricted shares to employees		1,498		1,498
Dividends	[2]	(937)			(937)
Ending Balance (in shares) at Sep. 30, 2019			21,256,000
Balance at end of year at Sep. 30, 2019		$ 247,925	$ 213	$ 261,959	$ 22,634	$ (36,881)
[1]	Cash dividends declared per share of common stock were $0.1275 and $0.1275 in the nine months ended September 30, 2018 and 2019, respectively.
[2]	Cash dividends declared per share of common stock were $0.1275 and $0.1275 in the nine months ended September 30, 2018 and 2019, respectively.

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended	9 Months Ended
	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Stockholders' Equity [Abstract]
Stock issued for acquisition of Filament (in shares)	5,593,116
Dividend per share (usd per share)		$ 0.1275	$ 0.1275

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
OPERATING ACTIVITIES
Net (loss) income	$ (29,899)	$ (11,707)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	18,771	16,807
Impairment of goodwill	9,748	2,205
Amortization of financing costs	1,312	1,103
Deferred rent	0	357
Non-cash lease expense	1,050	0
Stock compensation expense	3,605	3,027
Undistributed equity in losses (earnings), net of taxes	395	(417)
Loss on early retirement of debt	0	66
SKU Rationalization	8,500	0
Changes in operating assets and liabilities (excluding the effects of business acquisitions):
Accounts receivable	(37,343)	(13,245)
Inventory	(66,195)	(51,392)
Prepaid expenses, other current assets and other assets	756	905
Accounts payable, accrued expenses and other liabilities	43,465	29,059
Income taxes receivable	1,442	(2,952)
Income taxes payable	4,434	(4,245)
NET CASH USED IN OPERATING ACTIVITIES	(39,959)	(30,429)
INVESTING ACTIVITIES
Purchases of property and equipment	(7,618)	(5,420)
Filament acquisition, net of cash acquired	0	(217,521)
NET CASH USED IN INVESTING ACTIVITIES	(7,618)	(222,941)
FINANCING ACTIVITIES
Proceeds from revolving credit facility	258,647	203,237
Repayments of revolving credit facility	(208,737)	(210,271)
Proceeds from term loan	0	275,000
Repayments of term loan	(2,063)	(1,375)
Proceeds from short term loan	0	216
Payments on short term loan	0	(206)
Payment of financing costs	0	(11,171)
Payment of equity issuance costs	0	(936)
Payments for capital leases	(18)	(67)
Payments of tax withholding for stock based compensation	(390)	(442)
Proceeds from the exercise of stock options	133	143
Cash dividends paid	(2,693)	(2,405)
NET CASH PROVIDED BY FINANCING ACTIVITIES	44,879	251,723
Effect of foreign exchange on cash	(188)	(190)
DECREASE IN CASH AND CASH EQUIVALENTS	(2,886)	(1,837)
Cash and cash equivalents at beginning of period	7,647	7,600
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 4,761	$ 5,763

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES Organization and business Lifetime Brands, Inc. (the “Company”) designs, sources and sells branded kitchenware, tableware and other products used in the home and markets its products under a number of brand names and trademarks, which are either owned or licensed by the Company, or through retailers’ private labels. The Company markets and sells its products principally on a wholesale basis to retailers. The Company also markets and sells a limited selection of its products directly to consumers through third parties and its own internet websites. Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist only of normal recurring accruals, considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report on Form 10-K”). Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. The Company’s business and working capital needs are highly seasonal, with a majority of sales occurring in the third and fourth quarters. In 2018 and 2017, net sales for the third and fourth quarters accounted for 62 % and 60 % of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period. Revenue recognition The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and returns are reflected as reductions of revenue at the time of sale. See Note B – Revenue for additional information. Cost of sales Cost of sales consists primarily of costs associated with the production and procurement of products, inbound freight costs, purchasing costs, royalties, tooling, and other product procurement related charges. Prior to January 1, 2019, depreciation associated with certain tooling used to produce products was classified as selling, general and administrative expenses. The amount recorded in cost of sales for the three and nine months ended September 30, 2019 was $0.4 million and $1.1 million, respectively. The impact on the comparative periods presented is immaterial and therefore, the comparative periods have not been adjusted to reflect this change in accounting policy. The Company implemented programs to improve the productivity of its inventory and simplify its U.S. business. In connection therewith, it initiated a stock keeping unit rationalization (“SKU Rationalization”) initiative to identify inventory to discontinue from active status, consistent with the objectives of these programs. During the nine months ended September 30, 2019, the Company recorded an $8.5 million charge to cost of sales associated with the SKU Rationalization initiative. The inventory charge, which was recognized in cost of sales during the three months ended June 30, 2019, represented approximately 8% of the Company's consolidated inventory at June 30, 2019. Distribution expenses Distribution expenses consist primarily of warehousing expenses and freight-out expenses. Accounts receivable The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated losses that could result from the inability of its customers to make required payments. A considerable amount of judgment is required to assess the ultimate potential realization of these receivables including assessing the initial and on-going creditworthiness of the Company’s customers. The Company also maintains an allowance for anticipated customer deductions. The allowances for deductions are primarily based on contracts with customers. However, in certain cases, the Company does not have a formal contract and, therefore, customer deductions are non-contractual. To evaluate the reasonableness of non-contractual customer deductions, the Company analyzes currently available information and historical trends of deductions. Receivable purchase agreement The Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company’s condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company’s unaudited condensed consolidated statements of operations. Pursuant to this agreement, the Company sold to HSBC $32.5 million and $81.7 million of receivables during the three and nine months ended September 30, 2019, respectively, and $20.7 million and $59.4 million of receivables during the three and nine months ended September 30, 2018, respectively. Charges of $0.2 million and $0.4 million related to the sale of the receivables are included in selling, general and administrative expenses in the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2019, respectively. Charges of $0.1 million and $0.3 million related to the sale of receivables are included in selling, general and administrative expenses in the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2018, respectively. At September 30, 2019 and September 30, 2018, $17.8 million and $13.6 million, respectively, of receivables sold were outstanding and due to HSBC Bank USA from customers. Inventory Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company’s manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product by product basis based on the current selling environment. If the estimated selling price is lower than the inventory’s cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The components of inventory were as follows (in thousands): September 30, December 31, 2018 Finished goods $ 221,863 $ 165,969 Work in process 140 375 Raw materials 7,944 7,257 Total $ 229,947 $ 173,601 Fair value of financial instruments The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its revolving credit facility, and term loan approximate fair value since such borrowings bear interest at variable market rates. Derivatives The Company accounts for derivative instruments in accordance with Accounting Standard Codification (“ASC”) Topic No. 815, Derivatives and Hedging . ASC Topic No. 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes have no net impact on earnings until the hedged item is recognized in earnings. The change in the fair value of hedges that qualify and are designated as part of a hedging relationship are included in accumulated other comprehensive loss and subsequently recognized in the Company’s unaudited condensed consolidated statements of operations to mirror the location of the hedged items impacting earnings. Changes in the fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company’s unaudited condensed statements of operations. Goodwill, intangible assets and long-lived assets Goodwill and intangible assets deemed to have indefinite lives are not amortized but, instead, are subject to an annual impairment assessment. Additionally, if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable, the Company would evaluate goodwill and other intangible assets for impairment at that time. As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment testing described in Accounting Standards Update (“ASU”) Topic No. 350, Intangibles – Goodwill and Other . If, after assessing qualitative factors, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the impairment test is unnecessary and the Company’s goodwill is considered to be unimpaired. However, if based on the Company’s qualitative assessment, it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test. The quantitative impairment test compares the carrying value of each reporting unit that has goodwill with the estimated fair value of the respective reporting unit. Should the carrying value of a reporting unit be in excess of the estimated fair value of that reporting unit, an impairment charge will be recorded to reduce the reporting unit to fair value. The Company also evaluates qualitative factors to determine whether or not its indefinite lived intangibles have been impaired and then performs quantitative tests if required. These tests can include the relief from royalty model or other valuation models. Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During the third quarter of 2019, the Company’s qualitative assessment of goodwill indicated triggering events in its European kitchenware business, which resulted in a $9.7 million non-cash impairment charge. There were no indicators of impairment in the U.S. reporting unit. See Note F – Intangible assets to the unaudited condensed consolidated financial statements included in this Quarterly Report for additional information. Leases The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are not material to the Company’s condensed consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. Employee healthcare The Company self-insures certain portions of its health insurance plans. The Company maintains an accrual for unpaid claims and estimated claims incurred but not yet reported (“IBNR”). Although management believes that it uses the best information available to estimate claims IBNR, actual claims may vary significantly from estimated claims. Restructuring expenses Costs associated with restructuring activities are recorded at fair value when a liability has been incurred. A liability has been incurred at the point of closure for any remaining operating lease obligations and at the communication date for severance. In connection with the Company’s March 2018 acquisition of Filament, the Company commenced a restructuring plan to integrate the operations of Filament with the Company’s operations and realize the savings expected from the synergies of the acquisition. During the nine months ended September 30, 2019, the Company incurred $0.4 million of Filament restructuring charges, primarily related to severance. During the three and nine months ended September 30, 2018, the Company incurred $0.6 million and $1.4 million, respectively, of Filament restructuring charges, primarily related to severance, of which $0.8 million was accrued at September 30, 2018. During the three and nine months ended September 30, 2019, the Company incurred $0.3 million and $0.7 million of restructuring expense, primarily related to severance, for the integration of its legal entities operating in Europe. In 2018, the Company finalized its integration plans for its European operations and took further steps to consolidate its operations. The Company will combine its physical locations in the U.K. in 2019 and expects to incur approximately $0.7 million of additional restructuring and integration charges in 2019. At September 30, 2019, $0.1 million of restructuring charges related to the European restructuring plan were accrued. Adoption of new accounting pronouncements Effective January 1, 2019, the Company adopted ASU 2016-02, Leases (Topic 842) (“ASC 842”) , which requires a lessee, in most leases, to initially recognize a lease liability for the obligation to make lease payments and an ROU asset for the right to use the underlying asset for the lease term. The Company adopted this standard using the cumulative-effect adjustment method and elected certain practical expedients allowed under the standard. Upon adoption, the Company recognized ROU assets and a lease liability of $90.9 million and $104.4 million, respectively. See Note D – Leases for additional information on the Company’s adoption of this standard. Effective January 1, 2019, the Company adopted ASU 2018-02, Income Statement- Reporting Comprehensive Income: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income , which addresses the effect on items within accumulated other comprehensive income (loss) of the change in the U.S. federal corporate tax rate due to the enactment of the Tax Cuts and Jobs Act (the “Tax Act”) on December 22, 2017. Upon adoption, the Company did not elect to reclassify the stranded income tax effects of the Tax Act from accumulated other comprehensive (loss) income to retained earnings.

REVENUE

REVENUE	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are recognized at the point in time the customer obtains control of the products in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are Free On Board (“FOB”) Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. Shipping and handling fees that are billed to customers in sales transactions are included in net sales and amounted to $1.0 million and $2.3 million for the three and nine months ended September 30, 2019, respectively, and $0.9 million and $2.2 million for the three and nine months ended September 30, 2018, respectively. Net sales exclude taxes that are collected from customers and remitted to the taxing authorities. The Company offers various sales incentives and promotional programs to its wholesale customers from time to time in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements represent forms of variable consideration and an estimate of sales returns are reflected as reductions in net sales in the Company’s condensed consolidated statements of operations. These estimates are based on historical experience and other known factors or as the most likely amount in a range of possible outcomes. On a quarterly basis, variable consideration is assessed on a portfolio approach in estimating the extent to which the components of variable consideration are constrained. Payment terms with customers vary by customer, but generally range from 30 to 90 days or at the point of sale for the Company’s retail direct sales. The Company incurs certain direct incremental costs to obtain contracts with customers, such as sales-related commissions, where the recognition period for the related revenue is less than one year. These costs are expensed as incurred and recorded within selling, general and administrative expenses in the condensed consolidated statements of operations. Incidental items that are immaterial in the context of the contract are expensed as incurred. The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three and nine months ended September 30, 2019 (in thousands): Three Months Ended Nine Months Ended U.S. Segment Kitchenware $ 99,257 $ 234,149 Tableware 57,332 112,543 Home Solutions 38,610 98,637 Total U.S. Segment 195,199 445,329 International Segment Kitchenware 16,406 42,918 Tableware 3,897 19,717 Total International Segment 20,303 62,635 Total net sales $ 215,502 $ 507,964 United States 179,565 417,657 United Kingdom 13,985 44,697 Rest of World 21,952 45,610 Total net sales $ 215,502 $ 507,964

ACQUISITION

ACQUISITION	9 Months Ended
	Sep. 30, 2019
Business Combinations [Abstract]
ACQUISITION	ACQUISITION On December 22, 2017, the Company entered into an agreement providing for the acquisition of Filament by the Company. The acquisition was completed on March 2, 2018. The aggregate consideration for Filament, after taking into account certain adjustments, was $294.4 million, consisting of $217.5 million of cash consideration and 5,593,116 newly issued shares of the Company’s common stock, with a value equal to $76.9 million based on the market value of the Company’s common stock as of March 2, 2018. The purchase price was allocated based on the Company’s final estimate of the fair value of the assets acquired and liabilities assumed, as follows (in thousands): Accounts receivable $ 26,224 Inventory 29,044 Other assets 5,620 Other liabilities (23,018) Deferred income tax (13,881) Goodwill and other intangibles 270,427 Total allocated value $ 294,416 Goodwill results from such factors as an assembled workforce. The total amount of goodwill is not expected to be deductible for tax purposes. The goodwill and other intangible assets are primarily included in the U.S. segment. Customer relationships are amortized on a straight-line basis over their estimated useful lives (see Note F – Intangible Assets). The three and nine months ended September 30, 2018 included the operations of Filament for the period from March 2, 2018, the date of acquisition, to September 30, 2018. The unaudited condensed consolidated statements of operations for the three months ended September 30, 2018 include $38.6 million of net sales contributed by Filament. The condensed consolidated statements of operations for the nine months ended September 30, 2018, include $77.2 million of net sales contributed by Filament. Unaudited Pro forma Results The following table presents the Company’s pro forma consolidated net sales, income (loss) before income taxes and equity in earnings (losses) and net income (loss) for the three and nine months ended September 30, 2018. The unaudited pro forma results include the historical statements of operations information of the Company and of Filament, giving effect to the Filament acquisition and related financing as if they had occurred at the beginning of the periods presented. Three Months Ended Nine Months Ended (in thousands, except per share data) Net sales $ 209,448 $ 502,079 Income (loss) before income taxes and equity in earnings (losses) 6,956 (15,416) Net income (loss) 6,145 (10,671) Basic and diluted income (loss) per common share 0.30 (0.52) The unaudited pro forma results do not include any revenue or cost reductions that may be achieved through the business combination or the impact of non-recurring items directly related to the business combination. The unaudited pro forma results are not necessarily indicative of the operating results that would have occurred if the Filament acquisition had been completed as of the date for which the pro forma financial information is presented. In addition, the unaudited pro forma results do not purport to project the future condensed consolidated operating results of the combined company.

LEASES

LEASES	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
LEASES	LEASES The Company adopted ASC 842 as of January 1, 2019, using the cumulative effective adjustment method wherein the Company applied the new leases standard at the adoption date. Accordingly, all periods prior to January 1, 2019 are presented in accordance with the previous ASC Topic 840 – Leases , and no retrospective adjustments were made to the comparative periods presented. Adoption of ASC 842 resulted in an increase to total assets and liabilities due to the recording of operating lease ROU assets and operating lease liabilities of approximately $90.9 million and $104.4 million, respectively, as of January 1, 2019. Finance leases are not material to the Company and were not impacted by the adoption of ASC 842, as finance lease liabilities and the corresponding assets were already recorded in the balance sheet under the previous guidance, ASC 840. The adoption did not materially impact the Company’s condensed consolidated statements of operations or cash flows. The Company has operating leases for corporate offices, distribution facilities, manufacturing plants, and certain vehicles. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheet. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. The Company also elected the package of practical expedients permitted within the new standard, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases in lease payments based on changes in index rates or usage, are not included in the ROU assets or liabilities. These are expensed as incurred and recorded as variable lease expense. ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the commencement date based on the net present value of fixed lease payments over the lease term. The Company’s lease term includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. ROU assets also include any advance lease payments. As most of the Company’s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The components of lease costs for the three and nine months ended September 30, 2019 were as follows (in thousands): Three Months Ended Nine Months Ended Operating lease costs: Fixed $ 4,796 $ 13,927 Total $ 4,796 $ 13,927 Supplemental cash flow information for the three and nine months ended September 30, 2019 was as follows (in thousands): Three Months Ended Nine Months Ended Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 4,902 $ 12,877 Total $ 4,902 $ 12,877 Three Months Ended Nine Months Ended Right-of-use assets obtained in exchange for new lease obligations: Operating leases $ 2,566 $ 118,054 Total $ 2,566 $ 118,054 The aggregate future lease payments for operating leases as of September 30, 2019 were as follows (in thousands): Operating 2019 (excluding the nine months ending September 30, 2019) $ 4,922 2020 17,655 2021 17,538 2022 17,642 2023 17,818 Thereafter 88,965 Total lease payments 164,540 Less: Interest (40,293) Present value of lease payments $ 124,247 Average lease terms and discount rates were as follows: September 30, 2019 Weighted-average remaining lease term (years) Operating leases 8.7 Weighted-average discount rate Operating leases 6.1 %

INVESTMENTS

INVESTMENTS	9 Months Ended
	Sep. 30, 2019
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS	INVESTMENTS The Company owns approximately a 30 % interest in Grupo Vasconia S.A.B. (“Vasconia”), an integrated manufacturer of aluminum products and one of Mexico’s largest housewares companies. Shares of Vasconia’s capital stock are traded on the Bolsa Mexicana de Valores, the Mexican Stock Exchange. The Quotation Key is VASCONI. The Company accounts for its investment in Vasconia using the equity method of accounting and records its proportionate share of Vasconia’s net income in the Company’s condensed consolidated statements of operations. Accordingly, the Company has recorded its proportionate share of Vasconia’s net income (reduced for amortization expense related to the customer relationships acquired) for the three and nine months ended September 30, 2019 and 2018 in the accompanying unaudited condensed consolidated statements of operations. The value of the Company's investment balance has been translated from Mexican Pesos ("MXN") to U.S. Dollars ("USD") using the spot rates of MXN 19.71 and MXN 19.64 at September 30, 2019 and December 31, 2018, respectively. The Company's proportionate share of Vasconia's net (loss) income has been translated from MXN to USD using the following exchange rates: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Average exchange rate (MXN to USD) 19.42 18.94 19.11 - 19.42 18.71-19.38 The effect of the translation of the Company’s investment resulted in a decrease to the investment of $1.8 million during the nine months ended September 30, 2019 and an increase to the investment of $0.8 million during the nine months ended 2018. These translation effects are recorded in accumulated other comprehensive income (loss). Summarized statement of income information for Vasconia in USD and MXN is as follows (in thousands): Three Months Ended 2019 2018 USD MXN USD MXN Net sales $ 36,566 $ 710,118 $ 41,222 $ 780,938 Gross profit 5,572 108,205 7,762 147,039 (Loss) income from operations (581) (11,288) 1,063 20,136 Net Loss (647) (12,571) (1,233) (23,361) Nine Months Ended 2019 2018 USD MXN USD MXN Net Sales $ 115,100 $ 2,216,293 $ 128,853 $ 2,452,673 Gross profit 22,801 438,478 24,867 473,763 Income from operations 4,117 78,739 5,867 112,466 Net (Loss) income (1,158) (22,384) 862 17,484 The Company recorded equity in (losses) earnings of Vasconia, net of taxes, of $(0.2) million and $(0.4) million for the three and nine months ended September 30, 2019, respectively. The Company recorded equity in (losses) earnings of Vasconia, net of taxes, of $0.2 million and $0.4 million for the three and nine months ended September 30, 2018, respectively. Equity in (losses) earnings for the three and nine months ended September 30, 2018 includes deferred tax benefit of $0.6 million and $0.3 million, respectively, due to the requirement to record tax benefits for foreign currency translation gains and losses through other comprehensive (loss) income, with a corresponding adjustment to deferred tax liabilities. Included within the Company's condensed consolidated balance sheets are the following amounts due to and due from Vasconia (in thousands): Vasconia due to and due from balances Balance Sheet September 30, 2019 December 31, 2018 Amounts due from Vasconia Prepaid expenses and other current assets $ 48 $ 95 Amounts due to Vasconia Accrued expenses and Accounts payable 90 — As of September 30, 2019 and December 31, 2018, the fair value (based upon Vasconia’s quoted stock price) of the Company’s investment in Vasconia was $33.3 million and $31.9 million, respectively. The carrying value of the Company’s investment in Vasconia was $20.3 million and $22.6 million as of September 30, 2019 and December 31, 2018, respectively.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	INTANGIBLE ASSETS Intangible assets consist of the following (in thousands): September 30, 2019 December 31, 2018 Gross Impairment Accumulated Net Gross Impairment Accumulated Net Goodwill $ 92,361 $ (9,748) — $ 82,613 $ 93,895 $ (2,205) $ — $ 91,690 Indefinite-lived intangible assets: Trade names 58,216 — — 58,216 58,216 — — 58,216 Finite-lived intangible assets: Licenses 15,847 — (10,173) 5,674 15,847 — (9,825) 6,022 Trade names 43,193 — (16,174) 27,019 43,689 — (13,965) 29,724 Customer relationships 174,366 — (36,332) 138,034 175,482 — (27,538) 147,944 Other 6,475 — (1,688) 4,787 6,510 — (1,259) 5,251 Total $ 390,458 $ (9,748) $ (64,367) $ 316,343 $ 393,639 $ (2,205) $ (52,587) $ 338,847 During the third quarter of 2019, the Company’s qualitative assessment of goodwill indicated triggering events in its European kitchenware reporting unit, resulting in the Company performing a quantitative assessment, that resulted in a $9.7 million non-cash goodwill impairment charge. In the third quarter of 2018 the Company incurred a non-cash goodwill impairment charge of $2.2 million related to the European tableware business. Furthermore, during the third quarter of 2019 the Company determined its European kitchenware and tableware reporting units had met the criteria to be combined into one reporting unit based on the guidance of ASC Topic No. 350, Intangibles - Goodwill and Other and ASC Topic No. 280, Segment Reporting. As a result of the goodwill impairment charges taken in both the third quarter of 2019 and 2018, the Company wrote off to zero the amount of goodwill associated with the European kitchenware and tableware reporting units, acquired in 2014 and 2011, respectively.

DEBT

DEBT	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
DEBT	DEBT The Company’s credit agreement (the “ABL Agreement”) with JPMorgan Chase Bank, N.A. (“JPMorgan”), includes a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $150.0 million, which facility will mature on March 2, 2023, and a loan agreement (the “Term Loan” and together with the ABL Agreement, the “Debt Agreements”) provides for a senior secured term loan credit facility in the original principal amount of $275.0 million, which will mature on February 28, 2025. The Term Loan facility will be repaid in quarterly payments, which commenced June 30, 2018, of principal equal to 0.25% of the original aggregate principal amount of the Term Loan facility. The Term Loan requires the Company to make an annual prepayment of principal based upon excess cash flow (the “Excess Cash Flow”), if any. This estimated amount is recorded in the current maturity of term loan on the unaudited condensed consolidated balance sheets. The maximum borrowing amount under the ABL Agreement may be increased to up to $200.0 million if certain conditions are met. One or more tranches of additional term loans (the “Incremental Facilities”) may be added under the Term Loan if certain conditions are met. The Incremental Facilities may not exceed the sum of (i) $50.0 million plus (ii) an unlimited amount so long as, in the case of (ii) only, the Company’s secured net leverage ratio, as defined in and computed pursuant to the Term Loan, is no greater than 3.75 to 1.00, subject to certain limitations and for the period defined pursuant to the Term Loan. At September 30, 2019 and December 31, 2018, borrowings outstanding under the ABL Agreement were $91.2 million and $42.1 million, respectively, and open letters of credit were $3.2 million and $3.4 million, respectively. At September 30, 2019, availability under the ABL Agreement was approximately $55.6 million. Availability under the ABL Agreement depends on the valuation of certain current assets comprising the borrowing base. Due to the seasonality of the Company’s business, this may mean that the Company will have greater borrowing availability during the third and fourth quarters of each year. The borrowing capacity under the ABL Agreement will depend, in part, on eligible levels of accounts receivable and inventory that fluctuate regularly. Consequently, the $150.0 million commitment there under may not represent actual borrowing capacity. The current and non current portions of the Company’s Term Loan facility included in the condensed consolidated balance sheets are presented as follows (in thousands): September 30, 2019 December 31, 2018 Current portion of Term Loan facility: Term Loan facility $ 2,750 $ 2,750 Estimated Excess Cash Flow payment 3,000 — Unamortized debt issuance costs (1,486) (1,497) Total Current portion of Term Loan facility $ 4,264 $ 1,253 Non Current portion of Term Loan facility: Term Loan facility $ 265,125 $ 270,188 Unamortized debt issuance costs (6,380) (7,493) Total Non Current portion of Term Loan facility $ 258,745 $ 262,695 The Company’s payment obligations under its Debt Agreements are unconditionally guaranteed by its existing and future U.S. subsidiaries with certain minor exceptions. Certain payment obligations under the ABL Agreement are also direct obligations of its foreign subsidiary borrowers designated as such under the ABL Agreement and, subject to limitations on such guaranty, are guaranteed by the foreign subsidiary borrowers, as well as by the Company. The obligations of the Company under the Debt Agreements and any hedging arrangements and cash management services and the guarantees by its domestic subsidiaries in respect of those obligations are secured by substantially all of the assets and stock (but in the case of foreign subsidiaries, limited to 65 % of the capital stock in first-tier foreign subsidiaries and not including the stock of subsidiaries of such first-tier foreign subsidiaries) owned by the Company and the U.S. subsidiary guarantors, subject to certain exceptions. Such security interest consists of (1) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and its domestic subsidiaries (the “ABL Collateral”) pledged as collateral in favor of lenders under the ABL Agreement and a second-priority lien in the ABL Collateral in favor of the lenders under the Term Loan and (2) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and its domestic subsidiaries (the “Term Loan Collateral”) pledged as collateral in favor of lenders under the Term Loan and a second-priority lien in the Term Loan Collateral in favor of the lenders under the ABL Agreement. Borrowings under the revolving credit facility bear interest, at the Company’s option, at one of the following rates: (i) alternate base rate, defined, for any day, as the greater of the prime rate, a federal funds and overnight bank funding based rate plus 0.5 % or one-month LIBOR plus 1 %, plus a margin of 0.25 % to 0.75 %, or (ii) LIBOR plus a margin of 1.25 % to 1.75 %. The respective margins are based upon the Company’s total leverage ratio, as defined in and computed pursuant to the ABL Agreement. Interest rates on outstanding borrowings under the ABL Agreement at September 30, 2019 ranged from 2.60 % to 6.00 %. In addition, the Company paid a commitment fee of 0.250 % to 0.375 % on the unused portion of the ABL Agreement during the nine months ended September 30, 2019. The term loan facility bears interest, at the Company’s option, at one of the following rates: (i) alternate base rate, defined, for any day, as the greater of the prime rate, a federal funds and overnight bank funding based rate plus 0.50 % or one-month LIBOR plus 1 %, plus a margin of 2.50 % or (ii) LIBOR plus a margin of 3.50 %. The interest rate on outstanding borrowings under the Term Loan at September 30, 2019 was 5.60 %. The Debt Agreements provide for customary restrictions and events of default. Restrictions include limitations on additional indebtedness, acquisitions, investments and payment of dividends, among other things. Further, the ABL Agreement provides that during any period (a) commencing on the last day of the most recently ended four consecutive fiscal quarters on or prior to the date availability under the ABL Agreement is less than the greater of $15.0 million and 10 % of the aggregate commitment under the ABL Agreement at any time and (b) ending on the day after such availability has exceeded the greater of $15.0 million and 10 % of the aggregate commitment under the ABL Agreement for forty-five (45) consecutive days, the Company is required to maintain a minimum fixed charge coverage ratio of 1.10 to 1.00 as of the last day of any period of four consecutive fiscal quarters. The Company was in compliance with the covenants of the Debt Agreements at September 30, 2019.

DERIVATIVES

DERIVATIVES	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVES	DERIVATIVES The Company is a party to interest rate swap agreements with an aggregate notional value of $100.0 million at September 30, 2019. The Company designated the interest rate swaps as cash flow hedges of the Company’s exposure to the variability of the payment of interest on a portion of its Term Loan borrowings. The hedge periods of these agreements commenced in April 2018 and expire in March 2023. The notional amounts are reduced over these periods. In June 2019, the Company entered into new interest rate swap agreements, with an aggregate notional value of $25.0 million at September 30, 2019. These non-designated interest rate swaps serve as cash flow hedges of the Company’s exposure to the variability of the payment of interest on a portion of its Term Loan borrowings and expire in February 2025. The Company is exposed to market risks as well as changes in foreign currency exchange rates as measured against the USD and each other, and changes to credit risk of derivative counterparties. The Company attempts to minimize these risks by primarily using foreign currency forward contracts and by maintaining counterparty credit limits. These hedging activities provide only limited protection against currency exchange and credit risk. Factors that could influence the effectiveness of the Company’s hedging programs include currency markets and availability of hedging instruments and liquidity of the credit markets. All foreign currency forward contracts that the Company enters into are components of hedging programs and are entered into for the sole purpose of hedging an existing or anticipated currency exposure. The Company does not enter into such contracts for speculative purposes and as of September 30, 2019, the Company does not have any foreign currency forward contract derivatives that are not designated as hedges. The aggregate gross notional value of foreign exchange contracts that were not designated as hedges at September 30, 2018 was $9.7 million. Fluctuations in the value of certain foreign currencies as compared to the USD may positively or negatively affect the Company’s revenues, gross margins, operating expenses, and retained earnings, all of which are expressed in USD. Where the Company deems it prudent, the Company engages in hedging programs using foreign currency forward contracts aimed at limiting the impact of foreign currency exchange rate fluctuations on earnings. The Company purchases short-term (i.e. 12 months or less) foreign currency forward contracts to protect against currency exchange risks associated with the payment of merchandise purchases to foreign suppliers. The Company does not hedge the translation of foreign currency profits into USD, as the Company regards this as an accounting exposure rather than an economic exposure. The aggregate gross notional values of foreign exchange contracts at September 30, 2019 was $4.5 million. These foreign exchange contracts have been designated as hedges in to order to apply hedge accounting. The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands): Derivatives designated as hedging instruments Balance Sheet September 30, 2019 December 31, 2018 Interest rate swaps Prepaid Expenses $ 495 $ 42 Other Assets 1,479 157 Foreign exchange contracts Prepaid Expenses 339 — Derivatives not designated as hedging instruments Balance Sheet September 30, 2019 December 31, 2018 Interest rate swaps Other Assets $ 717 $ — The fair values of the derivatives have been obtained from the counterparties to the agreements and were based on Level 2 observable inputs using proprietary models and estimates about relevant future market conditions. The counterparties to the derivative financial instruments are major international financial institutions. The Company is exposed to credit risk for the net exchanges under these agreements, but not for the notional amounts. The Company does not anticipate non-performance by any of its counterparties. The amounts of gains (losses) related to the Company’s derivative financial instruments designated as hedging instruments are recognized in other comprehensive (loss) income, net of taxes, as follows (in thousands): Three Months Ended Nine Months Ended Derivatives designated as hedging instruments 2019 2018 2019 2018 Interest rate swaps $ 107 $ (381) $ 1,331 $ (658) Foreign exchange contracts 44 — 398 — $ 151 $ (381) $ 1,729 $ (658) Gains (losses) on the interest rate swaps, designated as hedges, will be reclassified into earnings as interest expense as the interest on the debt is recognized. During the three and nine months ended September 30, 2019, the Company recognized $(0.1) million and $(0.2) million of interest expense related to the interest rate swaps, respectively. During the three and nine months ended September 30, 2018, the Company recognized $(0.1) million and $(0.3) million of interest expense related to the interest rate swaps, respectively. Gains (losses) on the foreign exchange contracts will be reclassified into cost of sales as the hedged merchandise purchases are sold. The amount recorded as a gain in cost of sales for the three and nine months ended September 30, 2019 was $0.2 million and $0.3 million, respectively. The amounts of the gains (losses) related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands): Three Months Ended Nine Months Ended Derivatives not designated as hedging instruments Location of gain (loss) 2019 2018 2019 2018 Interest rate swaps Interest expense $ 390 — $ 740 — Foreign exchange contracts Selling, general and administrative expense — $ (193) — $ (240)

STOCK COMPENSATION

STOCK COMPENSATION	9 Months Ended
	Sep. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK COMPENSATION	STOCK COMPENSATION Option Awards A summary of the Company’s stock option activity and related information for the nine months ended September 30, 2019 is as follows: Options Weighted- Weighted- Aggregate Options outstanding, January 1, 2019 1,548,825 $ 13.87 Grants 296,500 9.21 Exercises (75,000) 4.28 Cancellations (6,750) 13.34 Expirations (240,125) 13.93 Options outstanding, September 30, 2019 1,523,450 13.43 5.2 $ 7,200 Options exercisable, September 30, 2019 1,040,172 $ 14.44 3.3 $ 7,200 Total unrecognized stock option expense remaining (in thousands) $ 1,554 Weighted-average years expected to be recognized over 1.6 The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value that would have been received by the option holders had all option holders exercised their stock options on September 30, 2019. The intrinsic value is calculated for each in-the-money stock option as the difference between the closing price of the Company’s common stock on September 30, 2019 and the exercise price. Restricted Stock A summary of the Company’s restricted stock activity and related information for the nine months ended September 30, 2019 is as follows: Restricted Weighted- Non-vested restricted shares, January 1, 2019 326,545 $ 14.63 Grants 439,747 9.25 Vested (145,049) 14.49 Cancellations (24,537) 13.97 Non-vested restricted shares, September 30, 2019 596,706 $ 10.73 Total unrecognized compensation expense remaining (in thousands) $ 5,045 Weighted-average years expected to be recognized over 1.7 The fair value of restricted stock that vested during the nine months ended September 30, 2019 was $1.4 million. Performance shares Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined based on the attainment of specified performance goals, as determined by the Compensation Committee, by the end of the performance period. The shares are subject to the terms and conditions of the Company’s Amended and Restated 2000 Long Term Incentive Plan (the “Plan”). A summary of the Company’s performance-based award activity and related information for the nine months ended September 30, 2019 is as follows: Performance- Weighted- Non-vested performance-based awards, January 1, 2019 339,287 $ 14.82 Grants 158,525 9.19 Vested (66,761) 15.69 Cancellations (25,992) 15.44 Non-vested performance-based awards, September 30, 2019 405,059 $ 12.43 Total unrecognized compensation expense remaining (in thousands) $ 2,513 Weighted-average years expected to be recognized over 1.7 (1) Represents the target number of shares to be issued for each performance-based award. The total fair value of performance-based awards that vested during the nine months ended September 30, 2019 was $0.6 million. At September 30, 2019, there were 320,480 shares available for awards that could be granted under the Plan, assuming maximum performance of performance-based awards. The Company recorded stock compensation expense as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Stock Compensation Expense Components 2019 2018 2019 2018 Equity based stock option expense $ 206 $ 152 $ 454 $ 559 Restricted and performance-based stock awards expense 1,292 1,116 3,130 2,468 Stock compensation expense for equity based awards $ 1,498 $ 1,268 $ 3,584 $ 3,027 Liability based stock option expense 7 21 Total Stock Compensation Expense $ 1,505 $ 1,268 $ 3,605 $ 3,027

(LOSS) INCOME PER COMMON SHARE

(LOSS) INCOME PER COMMON SHARE	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
(LOSS) INCOME PER COMMON SHARE	(LOSS) INCOME PER COMMON SHARE Basic (loss) income per common share has been computed by dividing net (loss) income by the weighted-average number of shares of the Company’s common stock outstanding during the relevant period. Diluted (loss) income per common share adjusts net (loss) income and basic (loss) income per common share for the effect of all potentially dilutive shares of the Company’s common stock. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. The calculations of basic and diluted (loss) income per common share for the three and nine months ended September 30, 2019 and 2018 are as follows: Three Months Ended Nine Months Ended 2019 2018 2019 2018 (in thousands, except per share amounts) Net (loss) income – basic $ (13,519) $ 5,948 $ (29,899) $ (11,707) Weighted-average shares outstanding – basic 20,429 20,357 20,494 19,123 Effect of dilutive securities: Stock options and other stock awards — 124 — — Weighted-average shares outstanding – diluted 20,429 20,481 20,494 19,123 Basic (loss) income per common share $ (0.66) $ 0.29 $ (1.46) $ (0.61) Diluted (loss) income per common share $ (0.66) $ 0.29 $ (1.46) $ (0.61) Antidilutive Securities 2,128 1,361 2,246 1,746

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income tax (provision) of $(15.1) million and $(6.8) million for the three and nine months ended September 30, 2019, respectively, represent taxes on U.S. earnings and a reduced benefit on foreign losses at a combined effective income tax provision rate of 857.5% and (30.0)%, respectively. The negative rate for the nine months ended September 30, 2019 reflects tax expense on a pretax book loss. The effective tax rates for the three and nine months ended September 30, 2019 differ from the federal statutory rate of 21% primarily due to state and local taxes and the impact of non-deductible expenses, offset by a benefit for federal credits. Included within the non-deductible expenses is the European goodwill impairment of $9.7 million recorded in the three months ended September 30, 2019, which is not deductible for income tax purposes in the foreign jurisdiction. Income tax (provision) benefit of $(0.9) million and $4.7 million for the three and nine months ended September 30, 2018, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of 13.6 % and an income tax benefit rate of 27.8 %, respectively. The effective rate for the three months ended September 30, 2018 reflects the reduced U.S. corporate income tax rate offset by state taxes and non-deductible expenses and increased by foreign income taxes relating to uncertain tax positions and a reduced benefit for a carryback claim in a foreign jurisdiction. The effective rate for the nine months ended September 30, 2018 reflects the reduced U.S. corporate income tax rate, increased by state and local taxes and the impact of nondeductible expenses and offset by foreign taxes. The Company has identified the following jurisdictions as “major” tax jurisdictions: U.S. Federal, California, Massachusetts, New York, New Jersey, Illinois, Georgia and the United Kingdom. The Company’s 2015 U.S. Federal income tax return and New York State tax returns for years 2014-2016 remain under audit with no material assesments as of September 30, 2019. The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three-month periods ended September 30, 2019 and September 30, 2018.

BUSINESS SEGMENTS

BUSINESS SEGMENTS	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
BUSINESS SEGMENTS	BUSINESS SEGMENTS The Company has two reportable segments, U.S. and International. Prior to October 1, 2018, the U.S. segment was reported as two separate reportable segments, U.S. Wholesale and Retail Direct. The Company changed its reporting structure as of October 1, 2018 to reflect how the Company is managing its operations as well as what the chief operating decision maker reviews to make organizational decisions about resource allocations. Prior period segment information has been recast to reflect the current reportable segment structure of the Company. The Company has segmented its operations to reflect the manner in which management reviews and evaluates the results of its operations. The U.S. segment includes the Company’s primary domestic business that designs, markets and distributes its products to retailers, distributors and its internet websites. The International segment consists of certain business operations conducted outside the U.S. Management evaluates the performance of the U.S. and International segments based on net sales and income (loss) from operations. Such measures give recognition to specifically identifiable operating costs such as cost of sales, distribution expenses and selling, general and administrative expenses. Certain general and administrative expenses, such as senior executive salaries and benefits, stock compensation, director fees, and accounting, legal and consulting fees, are not allocated to the specific segments and are reflected as unallocated corporate expenses. The Company implemented its SKU Rationalization initiative to improve the productivity of its inventory and simplify its U.S. business. During the nine months ended September 30, 2019, the Company recorded an $8.5 million charge to cost of sales associated with the SKU Rationalization initiative, which negatively impacted income (loss) from operations for the U.S. segment. Three Months Ended Nine Months Ended 2019 2018 2019 2018 (in thousands) Net sales U.S. $ 195,199 $ 186,064 $ 445,329 $ 410,955 International 20,303 23,384 62,635 65,313 Total net sales $ 215,502 $ 209,448 $ 507,964 $ 476,268 Income (loss) from operations U.S. $ 24,328 $ 20,027 $ 24,036 $ 16,455 International (12,898) (2,522) (16,813) (5,946) Unallocated corporate expenses (4,501) (5,202) (15,126) (14,823) Income (loss) from operations $ 6,929 $ 12,303 $ (7,903) $ (4,314) Depreciation and amortization U.S. $ 5,094 $ 5,009 $ 15,575 $ 13,448 International 1,028 1,067 3,196 3,359 Total depreciation and amortization $ 6,122 $ 6,076 $ 18,771 $ 16,807 September 30, December 31, (in thousands) Assets U.S. $ 772,871 $ 604,532 International 105,975 94,210 Unallocated corporate 4,886 9,830 Total Assets $ 883,732 $ 708,572

CONTINGENCIES

CONTINGENCIES	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Wallace Silversmiths de Puerto Rico, Ltd. (“WSPR”), a wholly-owned subsidiary of the Company, operates a manufacturing facility in San Germán, Puerto Rico that is leased from the Puerto Rico Industrial Development Company (“PRIDCO”). In March 2008, the United States Environmental Protection Agency (the “EPA”) announced that the San Germán Ground Water Contamination site in Puerto Rico (the “Site”) had been added to the Superfund National Priorities List. On August 13, 2015, the EPA released its remedial investigation and feasibility study (“RI/FS”) for the Site. On December 11, 2015, the EPA issued the Record of Decision (“ROD”) for an initial operable unit, electing to implement its preferred remedy which consists of soil vapor extraction and dual-phase extraction/in-situ treatment. This selected remedy includes soil vapor extraction (“SVE”) to address soil (vadose zone) source areas at the Site, impermeable cover as necessary for the implementation of SVE, dual phase extraction in the shallow saprolite zone, and in-situ treatment as needed to address residual sources. The EPA’s estimated total net present worth cost for its selected remedy is $7.3 million.. In February 2017, the EPA indicated that it planned to expand its field investigation for the RI/FS to a second operable unit to further determine the nature and extent of the groundwater damage at and from the Site and to determine the nature of the remedial action needed. The EPA requested access to the property occupied by WSPR to install monitoring wells and to undertake groundwater sampling as part of this expanded investigation. WSPR consented to the EPA’s access request, subject to PRIDCO’s consent, as the property owner. In December 2018, the Company, WSPR, and other identified Potentially Responsible Parties affiliated with the Site entered into tolling agreements to extend the statute of limitations for potential claims for the recovery of response costs for the initial operable unit under Section 107 of CERCLA. The tolling agreements do not constitute in any way an admission or acknowledgment of any fact, conclusion of law or liability by the parties to the agreements. The EPA released its proposed plan for a second operable unit in July 2019. The public comment period for the proposed plan ended on September 10, 2019. On September 30, 2019, the EPA issued the ROD for operable unit 2 (“OU-2”), electing to implement its preferred remedy which consists of in-situ treatment of groundwater and a monitored natural attenuation (MNA) program including monitoring of the plume fringe at the Site. The EPA’s estimated total net present worth cost for its selected remedy is $17.3 million. WSPR never used the primary constituents of concern and did not take up its tenancy at the Site until after EPA had discovered the damage to the local water supply. The EPA has also issued notices of potential liability to numerous other entities affiliated with the Site, which used the constituents of concern. Accordingly, based on the above uncertainties and variables, it is not possible at this time for the Company to estimate its share of liability, if any, related to this matter. However, in the event of one or more definitive claims because of property damage asserted against the Company and adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material.

OTHER

OTHER	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
OTHER	OTHER Cash dividends Dividends declared in the nine months ended September 30, 2019 were as follows: Dividend per share Date declared Date of record Payment date $0.0425 03/12/2019 05/01/2019 05/15/2019 $0.0425 06/27/2019 08/01/2019 08/15/2019 $0.0425 08/06/2019 11/01/2019 11/15/2019 On February 15, 2019, May 15, 2019, and August 15, 2019 the Company paid dividends of $0.9 million, $0.9 million and $0.9 million, respectively, to shareholders of record on February 1, 2019, May 1, 2019, and August 1, 2019, respectively. In the three months ended September 30, 2019, the Company reduced retained earnings for the accrual of $0.9 million relating to the dividend payable on November 15, 2019. On November 7, 2019, the Board of Directors declared a quarterly dividend of $0.0425 per share payable on February 14, 2020 to shareholders of record on January 31, 2020. Supplemental cash flow information Nine Months Ended 2019 2018 (in thousands) Supplemental disclosure of cash flow information: Cash paid for interest $ 13,876 $ 11,003 Cash paid for taxes, net of refunds 938 2,527 Non-cash investing activities: Translation loss adjustment $ (4,032) $ (1,985) Components of accumulated other comprehensive loss, net Three Months Ended Nine Months Ended 2019 2018 2019 2018 (in thousands) Accumulated translation adjustment: Balance at beginning of period $ (35,374) $ (29,930) $ (33,727) $ (27,821) Translation (loss) gain during period (2,385) 124 (4,032) (1,985) Balance at end of period $ (37,759) $ (29,806) $ (37,759) $ (29,806) Accumulated deferred gains (losses) on cash flow hedges: Balance at beginning of period $ 1,739 $ (263) $ 161 $ 14 Amounts reclassified from accumulated other comprehensive loss: Settlement of cash flow hedge (143) — (166) (14) Change in unrealized gains (losses) 294 (381) 1,895 (644) Net change in cash flow hedges, net of taxes of $36, $127, $531, and $215 151 (381) 1,729 (658) Balance at end of period $ 1,890 $ (644) $ 1,890 $ (644) Accumulated effect of retirement benefit obligations: Balance at beginning of period $ (1,025) $ (1,483) $ (1,050) $ (1,518) Amounts reclassified from accumulated other comprehensive loss: (1) Amortization of actuarial losses, net of taxes 13 19 38 54 Balance at end of period $ (1,012) $ (1,464) $ (1,012) $ (1,464) Total accumulated other comprehensive loss at end of period $ (36,881) $ (31,914) $ (36,881) $ (31,914) (1) Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist only of normal recurring accruals, considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report on Form 10-K”). Operating results for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. The Company’s business and working capital needs are highly seasonal, with a majority of sales occurring in the third and fourth quarters. In 2018 and 2017, net sales for the third and fourth quarters accounted for 62 % and 60 % of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period.
Revenue recognition and Cost of sales	Revenue recognition The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and returns are reflected as reductions of revenue at the time of sale. See Note B – Revenue for additional information. Cost of sales Cost of sales consists primarily of costs associated with the production and procurement of products, inbound freight costs, purchasing costs, royalties, tooling, and other product procurement related charges. Prior to January 1, 2019, depreciation associated with certain tooling used to produce products was classified as selling, general and administrative expenses. The amount recorded in cost of sales for the three and nine months ended September 30, 2019 was $0.4 million and $1.1 million, respectively. The impact on the comparative periods presented is immaterial and therefore, the comparative periods have not been adjusted to reflect this change in accounting policy.
Distribution expenses	Distribution expenses Distribution expenses consist primarily of warehousing expenses and freight-out expenses.
Accounts receivable	Accounts receivable The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated losses that could result from the inability of its customers to make required payments. A considerable amount of judgment is required to assess the ultimate potential realization of these receivables including assessing the initial and on-going creditworthiness of the Company’s customers. The Company also maintains an allowance for anticipated customer deductions. The allowances for deductions are primarily based on contracts with customers. However, in certain cases, the Company does not have a formal contract and, therefore, customer deductions are non-contractual. To evaluate the reasonableness of non-contractual customer deductions, the Company analyzes currently available information and historical trends of deductions.
Receivable purchase agreement	Receivable purchase agreementThe Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company’s condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company’s unaudited condensed consolidated statements of operations.
Inventory	Inventory Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company’s manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product by product basis based on the current selling environment. If the estimated selling price is lower than the inventory’s cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.
Fair value of financial instruments	Fair value of financial instruments The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its revolving credit facility, and term loan approximate fair value since such borrowings bear interest at variable market rates.
Derivatives	Derivatives The Company accounts for derivative instruments in accordance with Accounting Standard Codification (“ASC”) Topic No. 815, Derivatives and Hedging . ASC Topic No. 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes have no net impact on earnings until the hedged item is recognized in earnings. The change in the fair value of hedges that qualify and are designated as part of a hedging relationship are included in accumulated other comprehensive loss and subsequently recognized in the Company’s unaudited condensed consolidated statements of operations to mirror the location of the hedged items impacting earnings. Changes in the fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company’s unaudited condensed statements of operations.
Goodwill, intangible assets and long-lived assets	Goodwill, intangible assets and long-lived assets Goodwill and intangible assets deemed to have indefinite lives are not amortized but, instead, are subject to an annual impairment assessment. Additionally, if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable, the Company would evaluate goodwill and other intangible assets for impairment at that time. As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the goodwill impairment testing described in Accounting Standards Update (“ASU”) Topic No. 350, Intangibles – Goodwill and Other . If, after assessing qualitative factors, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the impairment test is unnecessary and the Company’s goodwill is considered to be unimpaired. However, if based on the Company’s qualitative assessment, it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test. The quantitative impairment test compares the carrying value of each reporting unit that has goodwill with the estimated fair value of the respective reporting unit. Should the carrying value of a reporting unit be in excess of the estimated fair value of that reporting unit, an impairment charge will be recorded to reduce the reporting unit to fair value. The Company also evaluates qualitative factors to determine whether or not its indefinite lived intangibles have been impaired and then performs quantitative tests if required. These tests can include the relief from royalty model or other valuation models. Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During the third quarter of 2019, the Company’s qualitative assessment of goodwill indicated triggering events in its European kitchenware business, which resulted in a $9.7 million non-cash impairment charge. There were no indicators of impairment in the U.S. reporting unit. See Note F – Intangible assets to the unaudited condensed consolidated financial statements included in this Quarterly Report for additional information.
Leases	Leases The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are not material to the Company’s condensed consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized.
Employee healthcare	Employee healthcare The Company self-insures certain portions of its health insurance plans. The Company maintains an accrual for unpaid claims and estimated claims incurred but not yet reported (“IBNR”). Although management believes that it uses the best information available to estimate claims IBNR, actual claims may vary significantly from estimated claims.
Restructuring expenses	Restructuring expenses Costs associated with restructuring activities are recorded at fair value when a liability has been incurred. A liability has been incurred at the point of closure for any remaining operating lease obligations and at the communication date for severance.
Adoption of new accounting pronouncements	Adoption of new accounting pronouncements Effective January 1, 2019, the Company adopted ASU 2016-02, Leases (Topic 842) (“ASC 842”) , which requires a lessee, in most leases, to initially recognize a lease liability for the obligation to make lease payments and an ROU asset for the right to use the underlying asset for the lease term. The Company adopted this standard using the cumulative-effect adjustment method and elected certain practical expedients allowed under the standard. Upon adoption, the Company recognized ROU assets and a lease liability of $90.9 million and $104.4 million, respectively. See Note D – Leases for additional information on the Company’s adoption of this standard. Effective January 1, 2019, the Company adopted ASU 2018-02, Income Statement- Reporting Comprehensive Income: Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income , which addresses the effect on items within accumulated other comprehensive income (loss) of the change in the U.S. federal corporate tax rate due to the enactment of the Tax Cuts and Jobs Act (the “Tax Act”) on December 22, 2017. Upon adoption, the Company did not elect to reclassify the stranded income tax effects of the Tax Act from accumulated other comprehensive (loss) income to retained earnings.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Components of Inventory	The components of inventory were as follows (in thousands): September 30, December 31, 2018 Finished goods $ 221,863 $ 165,969 Work in process 140 375 Raw materials 7,944 7,257 Total $ 229,947 $ 173,601

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Summary of Company's Revenue Disaggregated by Geographic Region and Revenue	The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three and nine months ended September 30, 2019 (in thousands): Three Months Ended Nine Months Ended U.S. Segment Kitchenware $ 99,257 $ 234,149 Tableware 57,332 112,543 Home Solutions 38,610 98,637 Total U.S. Segment 195,199 445,329 International Segment Kitchenware 16,406 42,918 Tableware 3,897 19,717 Total International Segment 20,303 62,635 Total net sales $ 215,502 $ 507,964 United States 179,565 417,657 United Kingdom 13,985 44,697 Rest of World 21,952 45,610 Total net sales $ 215,502 $ 507,964

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	9 Months Ended
	Sep. 30, 2019
Business Combinations [Abstract]
Summary of Purchase Price Allocated Based on Estimated Fair Value of Assets and Liabilities	The purchase price was allocated based on the Company’s final estimate of the fair value of the assets acquired and liabilities assumed, as follows (in thousands): Accounts receivable $ 26,224 Inventory 29,044 Other assets 5,620 Other liabilities (23,018) Deferred income tax (13,881) Goodwill and other intangibles 270,427 Total allocated value $ 294,416
Summary of Pro Forma Consolidated Net Sales and Income (Loss) Before Income Taxes and Equity in Earnings	The following table presents the Company’s pro forma consolidated net sales, income (loss) before income taxes and equity in earnings (losses) and net income (loss) for the three and nine months ended September 30, 2018. The unaudited pro forma results include the historical statements of operations information of the Company and of Filament, giving effect to the Filament acquisition and related financing as if they had occurred at the beginning of the periods presented. Three Months Ended Nine Months Ended (in thousands, except per share data) Net sales $ 209,448 $ 502,079 Income (loss) before income taxes and equity in earnings (losses) 6,956 (15,416) Net income (loss) 6,145 (10,671) Basic and diluted income (loss) per common share 0.30 (0.52)

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Schedule of components of lease costs	The components of lease costs for the three and nine months ended September 30, 2019 were as follows (in thousands): Three Months Ended Nine Months Ended Operating lease costs: Fixed $ 4,796 $ 13,927 Total $ 4,796 $ 13,927
Schedule of supplemental cash flow information related to leases	Supplemental cash flow information for the three and nine months ended September 30, 2019 was as follows (in thousands): Three Months Ended Nine Months Ended Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 4,902 $ 12,877 Total $ 4,902 $ 12,877 Three Months Ended Nine Months Ended Right-of-use assets obtained in exchange for new lease obligations: Operating leases $ 2,566 $ 118,054 Total $ 2,566 $ 118,054
Aggregate future lease payments for operating and finance leases	The aggregate future lease payments for operating leases as of September 30, 2019 were as follows (in thousands): Operating 2019 (excluding the nine months ending September 30, 2019) $ 4,922 2020 17,655 2021 17,538 2022 17,642 2023 17,818 Thereafter 88,965 Total lease payments 164,540 Less: Interest (40,293) Present value of lease payments $ 124,247
Schedule of average lease terms and discount rates	Average lease terms and discount rates were as follows: September 30, 2019 Weighted-average remaining lease term (years) Operating leases 8.7 Weighted-average discount rate Operating leases 6.1 %

INVESTMENTS (Tables)

INVESTMENTS (Tables)	9 Months Ended
	Sep. 30, 2019
Equity Method Investments and Joint Ventures [Abstract]
Summarized Exchange Rate Translation from MXN to USD	The Company's proportionate share of Vasconia's net (loss) income has been translated from MXN to USD using the following exchange rates: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Average exchange rate (MXN to USD) 19.42 18.94 19.11 - 19.42 18.71-19.38
Summarized Income Statement Information for Vasconia in USD and MXN	Summarized statement of income information for Vasconia in USD and MXN is as follows (in thousands): Three Months Ended 2019 2018 USD MXN USD MXN Net sales $ 36,566 $ 710,118 $ 41,222 $ 780,938 Gross profit 5,572 108,205 7,762 147,039 (Loss) income from operations (581) (11,288) 1,063 20,136 Net Loss (647) (12,571) (1,233) (23,361) Nine Months Ended 2019 2018 USD MXN USD MXN Net Sales $ 115,100 $ 2,216,293 $ 128,853 $ 2,452,673 Gross profit 22,801 438,478 24,867 473,763 Income from operations 4,117 78,739 5,867 112,466 Net (Loss) income (1,158) (22,384) 862 17,484
Schedule of Amounts Due to and Due from Related Parties Current	Included within the Company's condensed consolidated balance sheets are the following amounts due to and due from Vasconia (in thousands): Vasconia due to and due from balances Balance Sheet September 30, 2019 December 31, 2018 Amounts due from Vasconia Prepaid expenses and other current assets $ 48 $ 95 Amounts due to Vasconia Accrued expenses and Accounts payable 90 —

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Components of Intangible Assets Included in Wholesale Segment	Intangible assets consist of the following (in thousands): September 30, 2019 December 31, 2018 Gross Impairment Accumulated Net Gross Impairment Accumulated Net Goodwill $ 92,361 $ (9,748) — $ 82,613 $ 93,895 $ (2,205) $ — $ 91,690 Indefinite-lived intangible assets: Trade names 58,216 — — 58,216 58,216 — — 58,216 Finite-lived intangible assets: Licenses 15,847 — (10,173) 5,674 15,847 — (9,825) 6,022 Trade names 43,193 — (16,174) 27,019 43,689 — (13,965) 29,724 Customer relationships 174,366 — (36,332) 138,034 175,482 — (27,538) 147,944 Other 6,475 — (1,688) 4,787 6,510 — (1,259) 5,251 Total $ 390,458 $ (9,748) $ (64,367) $ 316,343 $ 393,639 $ (2,205) $ (52,587) $ 338,847

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The current and non current portions of the Company’s Term Loan facility included in the condensed consolidated balance sheets are presented as follows (in thousands): September 30, 2019 December 31, 2018 Current portion of Term Loan facility: Term Loan facility $ 2,750 $ 2,750 Estimated Excess Cash Flow payment 3,000 — Unamortized debt issuance costs (1,486) (1,497) Total Current portion of Term Loan facility $ 4,264 $ 1,253 Non Current portion of Term Loan facility: Term Loan facility $ 265,125 $ 270,188 Unamortized debt issuance costs (6,380) (7,493) Total Non Current portion of Term Loan facility $ 258,745 $ 262,695

DERIVATIVES (Tables)

DERIVATIVES (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Values of Derivative Financial Instruments Included in Unaudited Condensed Consolidated Balance Sheets	The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands): Derivatives designated as hedging instruments Balance Sheet September 30, 2019 December 31, 2018 Interest rate swaps Prepaid Expenses $ 495 $ 42 Other Assets 1,479 157 Foreign exchange contracts Prepaid Expenses 339 — Derivatives not designated as hedging instruments Balance Sheet September 30, 2019 December 31, 2018 Interest rate swaps Other Assets $ 717 $ —
Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments	The amounts of gains (losses) related to the Company’s derivative financial instruments designated as hedging instruments are recognized in other comprehensive (loss) income, net of taxes, as follows (in thousands): Three Months Ended Nine Months Ended Derivatives designated as hedging instruments 2019 2018 2019 2018 Interest rate swaps $ 107 $ (381) $ 1,331 $ (658) Foreign exchange contracts 44 — 398 — $ 151 $ (381) $ 1,729 $ (658)
Gains and Losses Related to Derivative Financial Instruments Not Designated as Hedging Instruments	The amounts of the gains (losses) related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands): Three Months Ended Nine Months Ended Derivatives not designated as hedging instruments Location of gain (loss) 2019 2018 2019 2018 Interest rate swaps Interest expense $ 390 — $ 740 — Foreign exchange contracts Selling, general and administrative expense — $ (193) — $ (240)

STOCK COMPENSATION (Tables)

STOCK COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Stock Option Activity and Related Information	A summary of the Company’s stock option activity and related information for the nine months ended September 30, 2019 is as follows: Options Weighted- Weighted- Aggregate Options outstanding, January 1, 2019 1,548,825 $ 13.87 Grants 296,500 9.21 Exercises (75,000) 4.28 Cancellations (6,750) 13.34 Expirations (240,125) 13.93 Options outstanding, September 30, 2019 1,523,450 13.43 5.2 $ 7,200 Options exercisable, September 30, 2019 1,040,172 $ 14.44 3.3 $ 7,200 Total unrecognized stock option expense remaining (in thousands) $ 1,554 Weighted-average years expected to be recognized over 1.6
Summary of Restricted Stock Activity	A summary of the Company’s restricted stock activity and related information for the nine months ended September 30, 2019 is as follows: Restricted Weighted- Non-vested restricted shares, January 1, 2019 326,545 $ 14.63 Grants 439,747 9.25 Vested (145,049) 14.49 Cancellations (24,537) 13.97 Non-vested restricted shares, September 30, 2019 596,706 $ 10.73 Total unrecognized compensation expense remaining (in thousands) $ 5,045 Weighted-average years expected to be recognized over 1.7
Summary of Performance-based Award Activity	A summary of the Company’s performance-based award activity and related information for the nine months ended September 30, 2019 is as follows: Performance- Weighted- Non-vested performance-based awards, January 1, 2019 339,287 $ 14.82 Grants 158,525 9.19 Vested (66,761) 15.69 Cancellations (25,992) 15.44 Non-vested performance-based awards, September 30, 2019 405,059 $ 12.43 Total unrecognized compensation expense remaining (in thousands) $ 2,513 Weighted-average years expected to be recognized over 1.7 (1) Represents the target number of shares to be issued for each performance-based award.
Summary of Stock Compensation Expense	The Company recorded stock compensation expense as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, Stock Compensation Expense Components 2019 2018 2019 2018 Equity based stock option expense $ 206 $ 152 $ 454 $ 559 Restricted and performance-based stock awards expense 1,292 1,116 3,130 2,468 Stock compensation expense for equity based awards $ 1,498 $ 1,268 $ 3,584 $ 3,027 Liability based stock option expense 7 21 Total Stock Compensation Expense $ 1,505 $ 1,268 $ 3,605 $ 3,027

(LOSS) INCOME PER COMMON SHARE

(LOSS) INCOME PER COMMON SHARE (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Calculations of Basic and Diluted Income per Common Share	The calculations of basic and diluted (loss) income per common share for the three and nine months ended September 30, 2019 and 2018 are as follows: Three Months Ended Nine Months Ended 2019 2018 2019 2018 (in thousands, except per share amounts) Net (loss) income – basic $ (13,519) $ 5,948 $ (29,899) $ (11,707) Weighted-average shares outstanding – basic 20,429 20,357 20,494 19,123 Effect of dilutive securities: Stock options and other stock awards — 124 — — Weighted-average shares outstanding – diluted 20,429 20,481 20,494 19,123 Basic (loss) income per common share $ (0.66) $ 0.29 $ (1.46) $ (0.61) Diluted (loss) income per common share $ (0.66) $ 0.29 $ (1.46) $ (0.61) Antidilutive Securities 2,128 1,361 2,246 1,746

BUSINESS SEGMENTS (Tables)

BUSINESS SEGMENTS (Tables)	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
Segment Reporting Information	Three Months Ended Nine Months Ended 2019 2018 2019 2018 (in thousands) Net sales U.S. $ 195,199 $ 186,064 $ 445,329 $ 410,955 International 20,303 23,384 62,635 65,313 Total net sales $ 215,502 $ 209,448 $ 507,964 $ 476,268 Income (loss) from operations U.S. $ 24,328 $ 20,027 $ 24,036 $ 16,455 International (12,898) (2,522) (16,813) (5,946) Unallocated corporate expenses (4,501) (5,202) (15,126) (14,823) Income (loss) from operations $ 6,929 $ 12,303 $ (7,903) $ (4,314) Depreciation and amortization U.S. $ 5,094 $ 5,009 $ 15,575 $ 13,448 International 1,028 1,067 3,196 3,359 Total depreciation and amortization $ 6,122 $ 6,076 $ 18,771 $ 16,807 September 30, December 31, (in thousands) Assets U.S. $ 772,871 $ 604,532 International 105,975 94,210 Unallocated corporate 4,886 9,830 Total Assets $ 883,732 $ 708,572

OTHER (Tables)

OTHER (Tables)	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash Dividends Declared	Dividends declared in the nine months ended September 30, 2019 were as follows: Dividend per share Date declared Date of record Payment date $0.0425 03/12/2019 05/01/2019 05/15/2019 $0.0425 06/27/2019 08/01/2019 08/15/2019 $0.0425 08/06/2019 11/01/2019 11/15/2019
Supplemental Cash Flow Information	Supplemental cash flow information Nine Months Ended 2019 2018 (in thousands) Supplemental disclosure of cash flow information: Cash paid for interest $ 13,876 $ 11,003 Cash paid for taxes, net of refunds 938 2,527 Non-cash investing activities: Translation loss adjustment $ (4,032) $ (1,985)
Components of Accumulated Other Comprehensive Loss, Net	Components of accumulated other comprehensive loss, net Three Months Ended Nine Months Ended 2019 2018 2019 2018 (in thousands) Accumulated translation adjustment: Balance at beginning of period $ (35,374) $ (29,930) $ (33,727) $ (27,821) Translation (loss) gain during period (2,385) 124 (4,032) (1,985) Balance at end of period $ (37,759) $ (29,806) $ (37,759) $ (29,806) Accumulated deferred gains (losses) on cash flow hedges: Balance at beginning of period $ 1,739 $ (263) $ 161 $ 14 Amounts reclassified from accumulated other comprehensive loss: Settlement of cash flow hedge (143) — (166) (14) Change in unrealized gains (losses) 294 (381) 1,895 (644) Net change in cash flow hedges, net of taxes of $36, $127, $531, and $215 151 (381) 1,729 (658) Balance at end of period $ 1,890 $ (644) $ 1,890 $ (644) Accumulated effect of retirement benefit obligations: Balance at beginning of period $ (1,025) $ (1,483) $ (1,050) $ (1,518) Amounts reclassified from accumulated other comprehensive loss: (1) Amortization of actuarial losses, net of taxes 13 19 38 54 Balance at end of period $ (1,012) $ (1,464) $ (1,012) $ (1,464) Total accumulated other comprehensive loss at end of period $ (36,881) $ (31,914) $ (36,881) $ (31,914) (1) Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 01, 2019
Schedule Of Significant Accounting Policies [Line Items]
Percentage of total annual net sales in the third and fourth quarters								62.00%	60.00%
Cost of depreciation		$ 400			$ 1,100
Cost of sales		142,561		$ 135,663	336,683	$ 305,318
Inventory effected percentage			8.00%
Impairment of goodwill		9,748		2,205	9,748	2,205
Restructuring expenses		338		552	1,119	1,353
Right of use assets		108,323			108,323
Operating lease liability		124,247			124,247
Receivables Purchase Agreement
Schedule Of Significant Accounting Policies [Line Items]
Sale of receivables		32,500		20,700	81,700	59,400
Receivables sold outstanding		17,800		13,600	17,800	13,600
Receivables Purchase Agreement | Selling, general and administrative expense
Schedule Of Significant Accounting Policies [Line Items]
Charge related to sale of receivables		200		100	400	300
Stock Keeping Unit Rationalization Program
Schedule Of Significant Accounting Policies [Line Items]
Cost of sales					8,500
Accounting Standards Update 2016-02
Schedule Of Significant Accounting Policies [Line Items]
Right of use assets										$ 90,900
Operating lease liability										$ 104,400
Filament restructuring plan | Employee severance
Schedule Of Significant Accounting Policies [Line Items]
Restructuring expenses				600	400	1,400
Restructuring reserve		$ 100		$ 800	100	$ 800
Filament restructuring plan | Employee severance | Forecast
Schedule Of Significant Accounting Policies [Line Items]
Restructuring expenses	$ 700
European restructuring plan | Forecast
Schedule Of Significant Accounting Policies [Line Items]
Restructuring expenses							$ 300
European restructuring plan | Employee severance
Schedule Of Significant Accounting Policies [Line Items]
Restructuring expenses					$ 700

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Components of Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Finished goods	$ 221,863	$ 165,969
Work in process	140	375
Raw materials	7,944	7,257
Total	$ 229,947	$ 173,601

REVENUE - Additional Informatio

REVENUE - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Net sales	$ 215,502	$ 209,448	$ 507,964	$ 476,268
Shipping and Handling
Disaggregation of Revenue [Line Items]
Net sales	$ 1,000	$ 900	$ 2,300	$ 2,200

REVENUE - Summary of Company's

REVENUE - Summary of Company's Revenue Disaggregated by Geographic Region and Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Net sales	$ 215,502	$ 209,448	$ 507,964	$ 476,268
United States
Disaggregation of Revenue [Line Items]
Net sales	179,565		417,657
United Kingdom
Disaggregation of Revenue [Line Items]
Net sales	13,985		44,697
Rest of World
Disaggregation of Revenue [Line Items]
Net sales	21,952		45,610
U.S. Segment
Disaggregation of Revenue [Line Items]
Net sales	195,199		445,329
U.S. Segment | Kitchenware
Disaggregation of Revenue [Line Items]
Net sales	99,257		234,149
U.S. Segment | Tableware
Disaggregation of Revenue [Line Items]
Net sales	57,332		112,543
U.S. Segment | Home Solutions
Disaggregation of Revenue [Line Items]
Net sales	38,610		98,637
International Segment
Disaggregation of Revenue [Line Items]
Net sales	20,303		62,635
International Segment | Kitchenware
Disaggregation of Revenue [Line Items]
Net sales	16,406		42,918
International Segment | Tableware
Disaggregation of Revenue [Line Items]
Net sales	$ 3,897		$ 19,717

ACQUISITION - Additional Inform

ACQUISITION - Additional Information (Details) - Filament - USD ($) $ in Millions	Mar. 02, 2018	Sep. 30, 2018	Sep. 30, 2018
Business Acquisition [Line Items]
Aggregate acquisition agreement amount	$ 294.4
Cash consideration	$ 217.5
Newly issued shares of common stock (in shares)	5,593,116
Value of newly issued common stock	$ 76.9
Net sales		$ 38.6	$ 77.2

ACQUISITION - Summary of Purcha

ACQUISITION - Summary of Purchase Price Allocated Based on Estimated Fair Value of Assets and Liabilities (Details) - Filament $ in Thousands	Mar. 02, 2018USD ($)
Business Acquisition [Line Items]
Accounts receivable	$ 26,224
Inventory	29,044
Other assets	5,620
Other liabilities	(23,018)
Deferred income tax	(13,881)
Goodwill and other intangibles	270,427
Total allocated value	$ 294,416

ACQUISITION - Summary of Pro Fo

ACQUISITION - Summary of Pro Forma Consolidated Net Sales and Income (Loss) Before Income Taxes and Equity in Earnings (Details) - Filament - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018
Business Acquisition [Line Items]
Net sales	$ 209,448	$ 502,079
Income (loss) before income taxes and equity in earnings (losses)	6,956	(15,416)
Net income (loss)	$ 6,145	$ (10,671)
Basic and diluted income (loss) per common share (usd per share)	$ 0.30	$ (0.52)

LEASES - Additional Information

LEASES - Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right of use assets	$ 108,323
Operating lease liability	$ 124,247
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right of use assets		$ 90,900
Operating lease liability		$ 104,400

LEASES - Lease Cost (Details)

LEASES - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Operating lease costs:
Fixed	$ 4,796	$ 13,927
Total	$ 4,796	$ 13,927

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information Related To Leases (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases	$ 4,902	$ 12,877
Total	4,902	12,877
Right-of-use assets obtained in exchange for new lease obligations:
Operating leases	2,566	118,054
Total	$ 2,566	$ 118,054

LEASES - Maturities of Operatin

LEASES - Maturities of Operating Lease Liability (Details) $ in Thousands	Sep. 30, 2019USD ($)
Leases [Abstract]
2019 (excluding the nine months ending September 30, 2019)	$ 4,922
2020	17,655
2021	17,538
2022	17,642
2023	17,818
Thereafter	88,965
Total lease payments	164,540
Less: Interest	(40,293)
Present value of lease payments	$ 124,247

LEASES - Average Lease Terms An

LEASES - Average Lease Terms And Discount Rates (Details)	Sep. 30, 2019
Leases [Abstract]
Weighted-average remaining lease term (years), Operating leases	8 years 8 months 12 days
Weighted-average discount rate, Operating leases	6.10%

INVESTMENTS - Additional Inform

INVESTMENTS - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)$ / $	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)$ / $	Sep. 30, 2018USD ($)	Dec. 31, 2018USD ($)$ / $
Schedule of Equity Method Investments [Line Items]
Equity in earnings (losses), net of taxes	$ (210)	$ 185	$ (395)	$ 417
Grupo Vasconia S.A.B.
Schedule of Equity Method Investments [Line Items]
Percentage of ownership in equity method investment	30.00%		30.00%
Exchange rate at period end (MXN per USD) | $ / $	19.71		19.71		19.64
Increase (decrease) in equity method investment			$ (1,800)	800
Equity in earnings (losses), net of taxes		200		400
Equity in earnings, deferred taxes expense (benefit)		$ (600)		$ (300)
Fair value of investment	$ 33,300		33,300		$ 31,900
Carrying value of investment	$ 20,300		$ 20,300		$ 22,600

INVESTMENTS - Summary of Propor

INVESTMENTS - Summary of Proportionate Share of Vasconia's Net Income translated from MXN to USD (Details) - Grupo Vasconia S.A.B. - $ / $	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule of Equity Method Investments [Line Items]
Average daily exchange rate for period (MXN per USD)	19.42	18.94
Minimum
Schedule of Equity Method Investments [Line Items]
Average daily exchange rate for period (MXN per USD)			19.11	18.71
Maximum
Schedule of Equity Method Investments [Line Items]
Average daily exchange rate for period (MXN per USD)			19.42	19.38

INVESTMENTS - Summarized Statem

INVESTMENTS - Summarized Statement of Income Information for Vasconia in USD and MXN (Details) - Grupo Vasconia S.A.B. $ in Thousands, $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2019MXN ($)	Sep. 30, 2018USD ($)	Sep. 30, 2018MXN ($)	Sep. 30, 2019USD ($)	Sep. 30, 2019MXN ($)	Sep. 30, 2018USD ($)	Sep. 30, 2018MXN ($)
Income Statement [Abstract]
Net sales	$ 36,566	$ 710,118	$ 41,222	$ 780,938	$ 115,100	$ 2,216,293	$ 128,853	$ 2,452,673
Gross profit	5,572	108,205	7,762	147,039	22,801	438,478	24,867	473,763
(Loss) income from operations	(581)	(11,288)	1,063	20,136	4,117	78,739	5,867	112,466
Net Loss	$ (647)	$ (12,571)	$ (1,233)	$ (23,361)	$ (1,158)	$ (22,384)	$ 862	$ 17,484

INVESTMENTS- Schedule of Amount

INVESTMENTS- Schedule of Amounts Due to and Due From Vasconia (Details) - Grupo Vasconia S.A.B. - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Prepaid expenses and other current assets
Schedule of Equity Method Investments [Line Items]
Amounts due from Vasconia	$ 48	$ 95
Accrued expenses and Accounts payable
Schedule of Equity Method Investments [Line Items]
Amounts due to Vasconia	$ 90	$ 0

INTANGIBLE ASSETS - Components

INTANGIBLE ASSETS - Components of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Schedule of Intangible Assets Disclosure [Line Items]
Goodwill, Gross	$ 92,361	$ 93,895
Goodwill, Impairment	(9,748)	(2,205)
Goodwill, Net	82,613	91,690
Finite-lived intangible assets:
Finite-lived intangible assets, Accumulated Amortization	(64,367)	(52,587)
Total, Gross	390,458	393,639
Total, Net	316,343	338,847
Licenses
Finite-lived intangible assets:
Finite-lived intangible assets, Gross	15,847	15,847
Finite-lived intangible assets, Accumulated Amortization	(10,173)	(9,825)
Finite-lived intangible assets, Net	5,674	6,022
Trade names
Schedule of Intangible Assets Disclosure [Line Items]
Indefinite-lived intangible assets	58,216	58,216
Finite-lived intangible assets:
Finite-lived intangible assets, Gross	43,193	43,689
Finite-lived intangible assets, Accumulated Amortization	(16,174)	(13,965)
Finite-lived intangible assets, Net	27,019	29,724
Customer relationships
Finite-lived intangible assets:
Finite-lived intangible assets, Gross	174,366	175,482
Finite-lived intangible assets, Accumulated Amortization	(36,332)	(27,538)
Finite-lived intangible assets, Net	138,034	147,944
Other
Finite-lived intangible assets:
Finite-lived intangible assets, Gross	6,475	6,510
Finite-lived intangible assets, Accumulated Amortization	(1,688)	(1,259)
Finite-lived intangible assets, Net	$ 4,787	$ 5,251

INTANGIBLE ASSETS - Additional

INTANGIBLE ASSETS - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Goodwill [Line Items]
Goodwill	$ 82,613,000		$ 82,613,000		$ 91,690,000
Impairment of goodwill	9,748,000	$ 2,205,000	9,748,000	$ 2,205,000
Kitchenware | International Segment
Goodwill [Line Items]
Goodwill	0		0
Tableware | International Segment
Goodwill [Line Items]
Goodwill	$ 0		$ 0

DEBT - Additional Information (

DEBT - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
ABL Credit Agreement
Debt Instrument [Line Items]
Outstanding borrowing under credit facility	$ 91,200,000	$ 42,100,000
Open letters of credit	3,200,000	$ 3,400,000
Availability under revolving credit facility	55,600,000
Minimum availability under revolving credit to maintain minimum fixed charge ratio for four consecutive months	$ 15,000,000
Commitment fee percentage	10.00%
Minimum fixed charge coverage ratio	1.10
ABL Credit Agreement | One-month LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1.00%
Debt Agreements
Debt Instrument [Line Items]
Debt instrument, face amount	$ 275,000,000
Percentage of capital stock of foreign subsidiaries pledged as collateral	65.00%
Minimum term under revolving credit to maintain minimum fixed charge ratio	45 days
Term Loan
Debt Instrument [Line Items]
Debt instrument, quarterly repayment percentage of principal	0.25%
Maximum debt instrument leverage ratio	3.75
Interest rates on outstanding borrowings	5.60%
Term Loan | Alternate Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	2.50%
Term Loan | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	3.50%
Term Loan | Prime rate, federal funds and overnight bank funding based rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.50%
Senior Secured Asset Based Revolving Credit Facilities | ABL Credit Agreement
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 150,000,000
Line of credit facility maximum borrowing capacity if certain conditions are met	200,000,000
Senior Secured Asset Based Revolving Credit Facilities | Incremental Facilities
Debt Instrument [Line Items]
Increase in line of credit facility	$ 50,000,000
Revolving Credit Facility | ABL Credit Agreement | Prime rate, federal funds and overnight bank funding based rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.50%
Revolving Credit Facility | Minimum | ABL Credit Agreement
Debt Instrument [Line Items]
Interest rates on outstanding borrowings	2.60%
Percentage of line of credit facility unused capacity commitment fee	0.25%
Revolving Credit Facility | Minimum | ABL Credit Agreement | Alternate Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.25%
Revolving Credit Facility | Minimum | ABL Credit Agreement | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1.25%
Revolving Credit Facility | Maximum | ABL Credit Agreement
Debt Instrument [Line Items]
Interest rates on outstanding borrowings	6.00%
Percentage of line of credit facility unused capacity commitment fee	0.375%
Revolving Credit Facility | Maximum | ABL Credit Agreement | Alternate Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.75%
Revolving Credit Facility | Maximum | ABL Credit Agreement | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1.75%

DEBT - Current and non current

DEBT - Current and non current portions of Term Loan Facility (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Non Current portion of Term Loan facility:
Term Loan facility	$ 91,212	$ 42,080
Term Loan
Current portion of Term Loan facility:
Term Loan facility	2,750	2,750
Estimated Excess Cash Flow payment	3,000	0
Unamortized debt issuance costs- short term	(1,486)	(1,497)
Total Current portion of Term Loan facility	4,264	1,253
Non Current portion of Term Loan facility:
Term Loan facility	265,125	270,188
Unamortized debt issuance costs- long term	(6,380)	(7,493)
Total Non Current portion of Term Loan facility	$ 258,745	$ 262,695

DERIVATIVES - Additional Inform

DERIVATIVES - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Derivatives designated as hedging instruments | Foreign exchange contracts
Derivative [Line Items]
Notional amount	$ 4.5		$ 4.5
Derivatives designated as hedging instruments | Cash Flow Hedging | Interest rate swaps
Derivative [Line Items]
Notional amount	100		100
Derivatives not designated as hedging instruments | Interest rate swaps
Derivative [Line Items]
Notional amount	25		25
Derivatives not designated as hedging instruments | Foreign exchange contracts
Derivative [Line Items]
Notional amount		$ 9.7		$ 9.7
Interest expense | Interest rate swaps
Derivative [Line Items]
Gain (loss) reclassified into earnings		$ (0.1)	(0.2)	$ (0.3)
Cost of Sales | Foreign exchange contracts
Derivative [Line Items]
Gain (loss) reclassified into earnings	$ 0.2		$ 0.3

DERIVATIVES - Fair Values of De

DERIVATIVES - Fair Values of Derivative Financial Instruments Included in Consolidated Balance Sheets (Details) - Fair Value, Observable inputs, Level 2 - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid Expenses
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	$ 495	$ 42
Derivatives designated as hedging instruments | Interest rate swaps | Other Assets
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	1,479	157
Derivatives designated as hedging instruments | Foreign exchange contracts | Prepaid Expenses
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	339	0
Derivatives not designated as hedging instruments | Interest rate swaps | Other Assets
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	$ 717	$ 0

DERIVATIVES - Gains and Losses

DERIVATIVES - Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	$ 151	$ 982	$ 596	$ (381)	$ (263)	$ (14)	$ 1,729	$ (658)
Interest rate swaps
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	107			(381)			1,331	(658)
Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	$ 44			$ 0			$ 398	$ 0

DERIVATIVES - Gains and Losse_2

DERIVATIVES - Gains and Losses Related to Derivative Financial Instruments Not Designated as Hedging Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Interest expense | Interest rate swaps
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) on derivative financial instruments not designated as hedging instruments	$ 390	$ 0	$ 740	$ 0
Selling, general and administrative expense | Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) on derivative financial instruments not designated as hedging instruments	$ 0	$ (193)	$ 0	$ (240)

STOCK COMPENSATION - Summary of

STOCK COMPENSATION - Summary of Stock Option (Details)	9 Months Ended
	Sep. 30, 2019USD ($)$ / sharesshares
Options
Beginning balance (in shares) | shares	1,548,825
Grants (in shares) | shares	296,500
Exercises (in shares) | shares	(75,000)
Cancellations (in shares) | shares	(6,750)
Expirations (in shares) | shares	(240,125)
Ending balance (in shares) | shares	1,523,450
Options exercisable, end of period (in shares) | shares	1,040,172
Unrecognized stock option compensation cost | $	$ 1,554,000
Weighted-average years expected to be recognized over (in years)	1 year 7 months 6 days
Weighted- average exercise price
Beginning balance (usd per share) | $ / shares	$ 13.87
Grants (usd per share) | $ / shares	9.21
Exercises (usd per share) | $ / shares	4.28
Cancellations (usd per share) | $ / shares	13.34
Expirations (usd per share) | $ / shares	13.93
Ending balance (usd per share) | $ / shares	13.43
Weighted-average exercise price, Options exercisable, end of period (usd per share) | $ / shares	$ 14.44
Weighted- average remaining contractual life (years)
Options outstanding, end of period	5 years 2 months 12 days
Options exercisable, end of period	3 years 3 months 18 days
Aggregate intrinsic value
Options outstanding, end of period | $	$ 7,200
Options exercisable, end of period | $	$ 7,200

STOCK COMPENSATION - Summary _2

STOCK COMPENSATION - Summary of Restricted Stock Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)$ / sharesshares
Restricted Shares
Weighted-average years expected to be recognized over (in years)	1 year 7 months 6 days
Restricted Stock
Restricted Shares
Beginning balance (in shares) | shares	326,545
Grants (in shares) | shares	439,747
Vested (in shares) | shares	(145,049)
Cancellations (in shares) | shares	(24,537)
Ending balance (in shares) | shares	596,706
Total unrecognized compensation expense remaining (in thousands) | $	$ 5,045
Weighted-average years expected to be recognized over (in years)	1 year 8 months 12 days
Weighted- average grant date fair value
Beginning balance (usd per share) | $ / shares	$ 14.63
Grants (usd per share) | $ / shares	9.25
Vested (usd per share) | $ / shares	14.49
Cancellations (usd per share) | $ / shares	13.97
Ending balance (usd per share) | $ / shares	$ 10.73

STOCK COMPENSATION - Additional

STOCK COMPENSATION - Additional Information (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)shares
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of equity instruments	$ 1.4
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of equity instruments	$ 0.6
Number of shares range percentage	150.00%
Performance Shares | Amended and Restated Long Term Incentive Plan Two Thousand
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares) | shares	320,480

STOCK COMPENSATION - Summary _3

STOCK COMPENSATION - Summary of Performance-based Award Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2019USD ($)$ / sharesshares
Performance based stock awards
Weighted-average years expected to be recognized over (in years)	1 year 7 months 6 days
Performance Shares
Performance based stock awards
Beginning balance (in shares) | shares	339,287
Grants (in shares) | shares	158,525
Vested (in shares) | shares	(66,761)
Cancellations (in shares) | shares	(25,992)
Ending balance (in shares) | shares	405,059
Total unrecognized compensation expense remaining (in thousands) | $	$ 2,513
Weighted-average years expected to be recognized over (in years)	1 year 8 months 12 days
Weighted- average grant date fair value
Beginning balance (usd per share) | $ / shares	$ 14.82
Grants (usd per share) | $ / shares	9.19
Vested (usd per share) | $ / shares	15.69
Cancellations (usd per share) | $ / shares	15.44
Ending balance (usd per share) | $ / shares	$ 12.43

STOCK COMPENSATION - Summary _4

STOCK COMPENSATION - Summary of Stock Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	$ 1,505	$ 1,268	$ 3,605	$ 3,027
Equity based awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	1,498	1,268	3,584	3,027
Equity based stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	206	152	454	559
Restricted and performance-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	1,292	$ 1,116	3,130	$ 2,468
Liability based stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense	$ 7		$ 21

(LOSS) INCOME PER COMMON SHAR_2

(LOSS) INCOME PER COMMON SHARE - Calculations of Basic and Diluted Loss per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net (loss) income – basic	$ (13,519)	$ (11,513)	$ (4,867)	$ 5,948	$ (6,057)	$ (11,598)	$ (29,899)	$ (11,707)
Weighted-average shares outstanding - basic (in shares)	20,429			20,357			20,494	19,123
Effect of dilutive securities:
Weighted-average shares outstanding - diluted (in shares)	20,429			20,481			20,494	19,123
Basic (loss) income per common share (usd per share)	$ (0.66)			$ 0.29			$ (1.46)	$ (0.61)
Diluted (loss) income per common share (usd per share)	$ (0.66)			$ 0.29			$ (1.46)	$ (0.61)
Antidilutive securities (in shares)	2,128			1,361			2,246	1,746
Stock options and other stock awards
Effect of dilutive securities:
Stock options and other stock awards (in shares)	0			124			0	0

INCOME TAXES - Additional Infor

INCOME TAXES - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Examination [Line Items]
Income tax (provision) benefit	$ 15,066	$ 906	$ 6,813	$ (4,669)
Impairment of goodwill	$ 9,748	$ 2,205	$ 9,748	$ 2,205
Domestic Tax Authority
Income Tax Examination [Line Items]
Effective income tax benefit rate on US earnings, percent			857.50%	13.60%
Foreign
Income Tax Examination [Line Items]
Effective income tax benefit rate on foreign earnings, percent			(30.00%)	27.80%

BUSINESS SEGMENTS - Additional

BUSINESS SEGMENTS - Additional Information (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)segment
Segment Reporting [Abstract]
Number of reportable business segment | segment	2
SKU rationalization charged to cost of sales | $	$ 8.5

BUSINESS SEGMENTS - Segment Rep

BUSINESS SEGMENTS - Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Segment Reporting Information [Line Items]
Net sales	$ 215,502	$ 209,448	$ 507,964	$ 476,268
Income (loss) from operations	6,929	12,303	(7,903)	(4,314)
Depreciation and amortization	6,122	6,076	18,771	16,807
Assets	883,732		883,732		$ 708,572
Unallocated corporate expenses
Segment Reporting Information [Line Items]
Income (loss) from operations	(4,501)	(5,202)	(15,126)	(14,823)
Assets	4,886		4,886		9,830
U.S.
Segment Reporting Information [Line Items]
Depreciation and amortization	5,094	5,009	15,575	13,448
U.S. | Operating segments
Segment Reporting Information [Line Items]
Net sales	195,199	186,064	445,329	410,955
Income (loss) from operations	24,328	20,027	24,036	16,455
Assets	772,871		772,871		604,532
International
Segment Reporting Information [Line Items]
Depreciation and amortization	1,028	1,067	3,196	3,359
International | Operating segments
Segment Reporting Information [Line Items]
Net sales	20,303	23,384	62,635	65,313
Income (loss) from operations	(12,898)	$ (2,522)	(16,813)	$ (5,946)
Assets	$ 105,975		$ 105,975		$ 94,210

CONTINGENCIES - Additional Info

CONTINGENCIES - Additional Information (Details) - Capital cost $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
San German Ground Water Contamination Site, Initial Operable Unit
Site Contingency [Line Items]
Remedial alternative, EPA preferred remedy	$ 7.3
San German Ground Water Contamination Site, Second Operable Unit
Site Contingency [Line Items]
Remedial alternative, EPA preferred remedy	$ 17.3

OTHER - Cash Dividends Declared

OTHER - Cash Dividends Declared (Details) - $ / shares	Nov. 15, 2019	Aug. 15, 2019	May 15, 2019
Dividends Payable [Line Items]
Dividends per share (usd per share)		$ 0.0425	$ 0.0425
Subsequent Event
Dividends Payable [Line Items]
Dividends per share (usd per share)	$ 0.0425

OTHER - Additional Information

OTHER - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Nov. 07, 2019	Aug. 15, 2019	May 15, 2019	Feb. 15, 2019	Sep. 30, 2019	Sep. 30, 2018
Dividends Payable [Line Items]
Dividends paid to shareholders					$ 2,693	$ 2,405
Dividends payable					$ 900
Dividend per share (usd per share)					$ 0.1275	$ 0.1275
Dividend Paid
Dividends Payable [Line Items]
Dividends paid to shareholders		$ 900	$ 900	$ 900
Dividend Declared | Subsequent Event
Dividends Payable [Line Items]
Dividend per share (usd per share)	$ 0.0425

OTHER - Supplemental Cash Flow

OTHER - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 13,876	$ 11,003
Cash paid for taxes, net of refunds	938	2,527
Non-cash investing activities:
Translation loss adjustment	$ (4,032)	$ (1,985)

OTHER - Components of Accumulat

OTHER - Components of Accumulated Other Comprehensive Loss, Net (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of year	$ 263,104,000	$ 265,839,000	$ 279,493,000	$ 210,279,000
Balance at end of year	247,925,000	272,010,000	247,925,000	272,010,000
Accumulated translation adjustment:
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of year	(35,374,000)	(29,930,000)	(33,727,000)	(27,821,000)
Translation (loss) gain during period	(2,385,000)	124,000	(4,032,000)	(1,985,000)
Change in unrealized gains (losses)	(2,385,000)	124,000	(4,032,000)	(1,985,000)
Balance at end of year	(37,759,000)	(29,806,000)	(37,759,000)	(29,806,000)
Accumulated deferred gains (losses) on cash flow hedges:
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of year	1,739,000	(263,000)	161,000	14,000
Translation (loss) gain during period	294,000	(381,000)	1,895,000	(644,000)
Settlement of cash flow hedge	143,000	0	166,000	14,000
Change in unrealized gains (losses)	294,000	(381,000)	1,895,000	(644,000)
Net change in cash flow hedges, net of taxes of $36, $127, $531, and $215	151,000	(381,000)	1,729,000	(658,000)
Amortization of actuarial losses, net of taxes	(143,000)	0	(166,000)	(14,000)
Balance at end of year	1,890,000	(644,000)	1,890,000	(644,000)
Income tax expense (benefit)	36,000	127,000	531,000	215,000
Accumulated effect of retirement benefit obligations:
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of year	(1,025,000)	(1,483,000)	(1,050,000)	(1,518,000)
Settlement of cash flow hedge	(13,000)	(19,000)	(38,000)	(54,000)
Amortization of actuarial losses, net of taxes	13,000	19,000	38,000	54,000
Balance at end of year	(1,012,000)	(1,464,000)	(1,012,000)	(1,464,000)
Accumulated other comprehensive loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of year	(34,660,000)	(31,676,000)	(34,616,000)	(29,325,000)
Balance at end of year	$ (36,881,000)	$ (31,914,000)	$ (36,881,000)	$ (31,914,000)